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A B S T R A C T
Background
Women with suspected early-stage ovarian cancer need surgical staging which involves taking samples from areas within the abdominal
cavity and retroperitoneal lymph nodes in order to inform further treatment. One potential strategy is to surgically stage all women
with suspicious ovarian masses, without any histological information during surgery. This avoids incomplete staging, but puts more
women at risk of potential surgical over-treatment.
A second strategy is to perform a two-stage procedure to remove the pelvic mass and subject it to paraffin sectioning, which involves
formal tissue fixing with formalin and paraffin embedding, prior to ultrathin sectioning and multiple site sampling of the tumour.
Surgeons may then base further surgical staging on this histology, reducing the rate of over-treatment, but conferring additional surgical
and anaesthetic morbidity.
A third strategy is to perform a rapid histological analysis on the ovarian mass during surgery, known as ’frozen section’. Tissues are
snap frozen to allow fine tissue sections to be cut and basic histochemical staining to be performed. Surgeons can perform or avoid
the full surgical staging procedure depending on the results. However, this is a relatively crude test compared to paraffin sections,
which take many hours to perform.With frozen section there is therefore a risk of misdiagnosing malignancy and understaging women
subsequently found to have a presumed early-stage malignancy (false negative), or overstaging women without a malignancy (false
positive). Therefore it is important to evaluate the accuracy and usefulness of adding frozen section to the clinical decision-making
process.
Objectives
To assess the diagnostic test accuracy of frozen section (index test) to diagnose histopathological ovarian cancer in womenwith suspicious
pelvic masses as verified by paraffin section (reference standard).
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Search methods
We searched MEDLINE (January 1946 to January 2015), EMBASE (January 1980 to January 2015) and relevant Cochrane registers.
Selection criteria
Studies that used frozen section for intraoperative diagnosis of ovarian masses suspicious of malignancy, provided there was sufficient
data to construct 2 x 2 tables. We excluded articles without an available English translation.
Data collection and analysis
Authors independently assessed the methodological quality of included studies using the Quality Assessment of Diagnostic Accuracy
Studies tool (QUADAS-2) domains: patient selection, index test, reference standard, flow and timing. Data extraction converted 3 x
3 tables of per patient results presented in articles into 2 x 2 tables, for two index test thresholds.
Main results
All studies were retrospective, and the majority reported consecutive sampling of cases. Sensitivity and specificity results were available
from38 studies involving 11,181 participants (3200with invasive cancer, 1055with borderline tumours and 6926with benign tumours,
determined by paraffin section as the reference standard). The median prevalence of malignancy was 29% (interquartile range (IQR)
23% to 36%, range 11% to 63%). We assessed test performance using two thresholds for the frozen section test. Firstly, we used a test
threshold for frozen sections, defining positive test results as invasive cancer and negative test results as borderline and benign tumours.
The average sensitivity was 90.0% (95% confidence interval (CI) 87.6% to 92.0%; with most studies typically reporting range of 71%
to 100%), and average specificity was 99.5% (95% CI 99.2% to 99.7%; range 96% to 100%).
Similarly, we analysed sensitivity and specificity using a second threshold for frozen section, where both invasive cancer and borderline
tumours were considered test positive and benign cases were classified as negative. Average sensitivity was 96.5% (95% CI 95.5% to
97.3%; typical range 83% to 100%), and average specificity was 89.5% (95% CI 86.6% to 91.9%; typical range 58% to 99%).
Results were available from the same 38 studies, including the subset of 3953 participants with a frozen section result of either borderline
or invasive cancer, based on final diagnosis of malignancy. Studies with small numbers of disease-negative cases (borderline cases) had
more variation in estimates of specificity. Average sensitivity was 94.0% (95% CI 92.0% to 95.5%; range 73% to 100%), and average
specificity was 95.8% (95% CI 92.4% to 97.8%; typical range 81% to 100%).
Our additional analyses showed that, if the frozen section showed a benign or invasive cancer, the final diagnosis would remain the
same in, on average, 94% and 99% of cases, respectively.
In cases where the frozen section diagnosis was a borderline tumour, on average 21% of the final diagnoses would turn out to be invasive
cancer.
In three studies, the same pathologist interpreted the index and reference standard tests, potentially causing bias. No studies reported
blinding pathologists to index test results when reporting paraffin sections.
In heterogeneity analyses, there were no statistically significant differences between studies with pathologists of different levels of
expertise.
Authors’ conclusions
In a hypothetical population of 1000 patients (290 with cancer and 80 with a borderline tumour), if a frozen section positive test
result for invasive cancer alone was used to diagnose cancer, on average 261 women would have a correct diagnosis of a cancer, and
706 women would be correctly diagnosed without a cancer. However, 4 women would be incorrectly diagnosed with a cancer (false
positive), and 29 with a cancer would be missed (false negative).
If a frozen section result of either an invasive cancer or a borderline tumour was used as a positive test to diagnose cancer, on average
280 women would be correctly diagnosed with a cancer and 635 would be correctly diagnosed without. However, 75 women would
be incorrectly diagnosed with a cancer and 10 women with a cancer would be missed.
The largest discordance is within the reporting of frozen section borderline tumours. Investigation into factors leading to discordance
within centres and standardisation of criteria for reporting borderline tumours may help improve accuracy. Some centres may choose to
perform surgical staging in women with frozen section diagnosis of a borderline ovarian tumour to reduce the number of false positives.
In their interpretation of this review, readers should evaluate results from studies most typical of their population of patients.
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P L A I N L A N G U A G E S U M M A R Y
Is a ’quick diagnosis’ test on an ovarian mass during surgery accurate?
The issue
When women go to their doctor with a mass that could be ovarian cancer, they are normally referred for surgery, since the mass may
need to be removed and examined microscopically in a laboratory in a procedure known as paraffin section histopathology. A third of
women with ovarian cancer present with a cyst or mass without any visible evidence of spread elsewhere. However, in these apparently
early-stage cancers (confined to the ovary) surgical staging is required to decide if chemotherapy is required. This staging consists of
sampling tissues within the abdomen, including lymph nodes.
Different staging strategies exist. One is to perform surgical staging for all women who might have a cancer, to get information about
spread. This may result in complications due to additional surgical procedures that may turn out to be unnecessary in approximately
two thirds of women.
A second strategy is to perform an operation to remove just the suspicious mass and await the paraffin section diagnosis. This may result
in needing a further operation in one third of women if cancer is confirmed, putting them at increased risks from another operation.
A third strategy is to send the mass to the laboratory during the operation for a quick diagnosis, known as ’frozen section’. This helps
the surgeon decide if further surgical treatment is required during a single operation.
Why is this review important?
Frozen section is not as accurate as the traditional slower paraffin section examination, and it entails a risk of incorrect diagnosis,
meaning that some women may not have all the samples taken at the initial surgery and may need to undergo a second operation; and
others may undergo unnecessary surgical sampling.
How was this review conducted?
We searched all available studies reporting use of frozen section in women with suspicious ovarian masses. We excluded studies without
an English translation and studies without enough information to allow us to analyse the data.
What are the findings?
We included 38 studies (11,181 women), reporting three types of diagnoses from the frozen section test.
1. Cancer, which occurred in an average of 29% of women.
2. Borderline tumour, which occurred in 8% of women.
3. Benign mass.
In a hypothetical group of 1000 patients where 290 have cancer and 80 have a borderline tumour, 261 women would receive a correct
diagnosis of a cancer and 706 women would be correctly diagnosed without a cancer based on a frozen section result. However, 4
women would be incorrectly diagnosed as having a cancer where none existed (false positive), and 29 women with cancer would be
missed and potentially need further treatment (false negative).
If surgeons used a frozen section result of either a cancer or a borderline tumour to diagnose cancer, 280 women would be correctly
diagnosed with a cancer and 635 women would be correctly diagnosed without a cancer. However, 75 women would be incorrectly
diagnosed as having a cancer, and 10 women with cancer would be missed on the initial test and found to have a cancer after surgery.
If the frozen section result reported the mass as benign or malignant, the final diagnosis would remain the same in, on average, 94%
and 99% of the cases, respectively.
In cases where the frozen section diagnosis was a borderline tumour, there is a chance that the final diagnosis would turn out to be a
cancer in, on average, 21% of women.
What does this mean?
Where the frozen section diagnosis is a borderline tumour, the diagnosis is less accurate than for benign or malignant tumours. Surgeons
may choose to perform additional surgery in this group of women at the time of their initial surgery in order to reduce the need for a
second operation if the final diagnosis turns out to be a cancer, as it would on average in one out of five of these women.
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B A C K G R O U N D
Target condition being diagnosed
In 2012, 238,719 women worldwide were diagnosed with epithe-
lial ovarian cancer (EOC), and 151,905 died from the disease,
corresponding to an annual incidence of 6.1 cases per 100,000
women, an annual mortality rate of 4.3 deaths per 100,000 and a
cumulative lifetime risk of 0.5% (GLOBOCAN 2012). Ovarian
cancer is the sixth most common cancer and the seventh most
common cause of cancer death in women. Awoman’s risk of devel-
oping cancer of the ovary by age 75 years varies between countries,
ranging from 0.5% to 1.6%. This corresponds to an age-standard-
ised rate of ovarian cancer from 5 to 14 cases per year in 100,000
women under 75. In Europe, 30% to 44% of women with ovar-
ian cancer are alive five years after diagnosis (EUROCARE 2003).
The poor survival associated with ovarian cancer is largely because
most women are diagnosed when the cancer is already at an ad-
vanced stage (Jemal 2008), with only 30% being early-stage, that
is, confined to the ovary (NCIN 2015).
Early-stage ovarian cancer, or stage I and II according to the Inter-
national Federation of Gynecology and Obstetrics (FIGO 2015),
has a combined incidence of less than 35%, with five-year survival
rates of 92% and 55% for stage I and stage II, respectively (Cancer
Research UK 2012) (Appendix 1).
Currently, women presenting with a pelvic mass suspected of be-
ing ovarian cancer are triaged according to the risk of malignancy
index (RMI) (Bailey 2006; Jacobs 1990). RMI is a product (RMI
= U x M x CA125) of suspicious ultrasound features of the mass
(multilocular cysts, solid areas, metastases, ascites and bilateral le-
sions),menopausal status (postmenopausal = 3) and serumCA125
levels (IU/ml). There is some uncertainty as to the optimal thresh-
old for the RMI; however, women with high RMIs (e.g. > 200)
are usually scheduled for staging laparotomy at cancer centres.
Unlike advanced disease, early disease may not be obvious at
surgery. It is up to gynaecological cancer centres to decide how
they manage these masses. Some may choose to await final histol-
ogy before planning surgical staging; others may opt to surgically
stage those with high RMI; and others may employ frozen section
analysis to provide an intraoperative diagnosis.
The value of surgical staging is to detect micrometastases, present
in approximately 25% cases of invasive epithelial ovarian cancer,
which are notmacroscopically evident andwouldwarrant adjuvant
chemotherapy (Helewa 1986).
Index test(s)
Intraoperative frozen section histopathological analysis of a suspi-
cious pelvicmassmay facilitate the appropriate selection of women
requiring surgical staging. Frozen sections are not routinely per-
formed in all gynaecological cancer units in the United Kingdom;
as a result, optimal surgical staging may be omitted at primary la-
parotomy, particularly in early-stage disease. In the ICON 1 trial,
adjuvant platinum-based chemotherapy offered improved overall
survival in clinically stage I disease (ICON 1). This study included
93% of cases with clinically early-stage disease who underwent
hysterectomy, bilateral salpingo-oophorectomy and omentectomy
as a minimum surgical procedure. Optimal staging was therefore
not performed.
The importance of optimal surgical stagingwas further highlighted
in the ACTION study (Trimbos 2003), which showed that in a
subgroup analysis on the effect of surgical staging, the benefit of
adjuvant chemotherapy appeared to be limited to patients who
underwent suboptimal staging and so had a higher risk of un-
detected residual disease. In a subgroup analysis of patients with
optimal surgical staging, adjuvant chemotherapy was not associ-
ated with overall or recurrence-free survival. Optimal staging was
shown to be an independent prognostic factor for progression-
free and overall survival. Optimal staging included omentectomy,
washings, peritoneal biopsies, and pelvic and paraaortic lymph
node sampling. Women with early stage epithelial ovarian cancer
who undergo optimal surgical staging survive longer than those
suboptimally staged (Trimbos 2010). However, this benefit of sur-
gical staging did not reach significance in a recent Cochrane review
update of these studies with 10-year outcome data (Lawrie 2015).
If the frozen section shows a suspicious pelvic mass to be benign, a
full staging procedure is not necessary, and fertility-sparing surgery
could be offered if appropriate. Unnecessary surgical staging can
lead to lymphoedema, lymphocyst formation, and visceral and
neurovascular injury. Lymphoedema and lymphocyst formation
are often chronic conditions that can negatively affect quality of
life.
If the frozen section shows a borderline or malignant ovarian tu-
mour, surgeons often perform optimal staging. Therefore, the po-
tential benefits of performing intraoperative frozen section in-
clude: reducing surgical morbidity associated with unnecessary
optimal surgical staging; reducing the need for a second surgical
procedure to complete surgical staging where it has been subopti-
mal; and reducing operating costs.
Several studies and reviews have reported high sensitivity, speci-
ficity and overall accuracy when comparing intraoperative frozen
section with paraffin section examination (Cross 2012; Gol 2003;
Medeiros 2005; Naik 2006).
Clinical pathway
Most women with suspected early ovarian cancer undergo sur-
gical staging to identify metastases. This optimally includes in-
spection and palpation of peritoneal cavity and organs, biopsy
of peritoneum and suspicious nodules, peritoneal washings, to-
tal abdominal hysterectomy (TAH), bilateral salpingo-oophorec-
tomy (BSO), omentectomy, and retroperitoneal lymph node as-
sessment and sampling. An appendicectomy can be performed if
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the tumour is mucinous. Failure to complete the above staging
in cases of malignancy is called suboptimal staging. Diagnosis is
confirmed by paraffin section examination of surgical specimens,
which is usually reported a few days after the surgery. This is the
’gold standard’ of histopathological reporting (Figure 1).
Figure 1. Flow diagram showing clinical pathway if no frozen section available and staging offered based on
paraffin section
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When centres use paraffin sections to guide management rather
than frozen sections, a second surgical procedure may be required
in order to complete staging in women with confirmed ovarian
cancer. This may increase anxiety in addition to increasing the risk
of surgical and anaesthetic morbidity.
Where frozen section is used in the clinical pathway, it is used
on the same tissue samples as will be used for paraffin section,
but allows decisions about the need for further surgical staging
to be made within the same operation. Where the frozen section
result is benign, patients need only be offered further surgical
staging if the subsequent paraffin section result is malignant (
Figure 2).Where the frozen section result ismalignant, patients can
be offered immediate surgical stagingwithout the need for a second
surgery (Figure 2). Where the frozen section result is borderline,
there are two options (Figure 3). In option 1, the clinical team
and patient agree in advance to await the paraffin section result,
with further surgical staging or adjuvant chemotherapy offered if
subsequent paraffin result is malignant. In option 2, they agree
in advance to proceed to immediate surgical staging. Adjuvant
chemotherapy decisions are made on the basis of paraffin section
test results (Figure 1, Figure 2, Figure 3).
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Figure 2. Flow diagram showing clinical pathway for frozen section benign or malignant and surgical staging
offered. Example average numbers are shown for a hypothetical population of 1000 women, with prevalences
of malignancy 29%, borderline 8%, benign 63%. Prevalences are based on averages across all included studies.
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Figure 3. Flow diagram showing clinical pathway options (stage or not to stage) for borderline frozen section
diagnosis. Example average numbers are shown for a hypothetical population of 1000 women, with prevalences
of malignancy 29%, borderline 8%, benign 63%. Prevalences are based on averages across all included studies.
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In women with macroscopically evident stage III disease, there is
no need to use frozen section to confirm malignancy. However, as
discussed earlier, there is a proportion of women with apparently
stage I disease who have microscopic involvement of paraaortic
lymph nodes or omentum and are upstaged after surgical staging.
These women are offered dual-agent chemotherapy with a taxane.
In women with low risk disease, that is, stage IA grade 1 disease;
or in those with comprehensively staged stage IB grade 1-2 dis-
ease, experts thought until recently that there was no survival ad-
vantage associated with adjuvant chemotherapy (Winter-Roach
2012). However, an update of these data suggest that there may be
a longer term advantage of chemotherapy, even in these women
(Lawrie 2015). For womenwhohave had suboptimal staging, clin-
icians should discuss a second surgical staging procedure or adju-
vant chemotherapy (NICE 2011). Therefore, the clinical conse-
quence of suboptimal surgical staging is that women who appear
to have low-risk stage I ovarian cancer may require adjuvant che-
motherapy.
In the cases of high risk disease, that, is stage IB grade 3; stage
IC and higher; and clear cell cancers, six cycles of adjuvant plat-
inum-based chemotherapy are recommended (NICE 2011). Due
to the good response rate to chemotherapy, early-stage serous ovar-
ian cancers are often treated with six cycles of adjuvant dual-
agent chemotherapy, including a taxane. With regard to clear
cell cancers, as the response to chemotherapy is often poor, there
may be a therapeutic benefit to performing lymphadenectomy in
case of micrometastases. It should be noted, however, that NICE
guidance recommends assessment of retroperitoneal lymph nodes
but not systematic or block dissection of retroperitoneal lymph
nodes in women with clinically apparent stage I disease. Maggioni
2006 demonstrated that patients undergoing systematic pelvic and
paraaortic lymphadenectomy compared to sampling were found
to have more micrometastases (22% versus 9%), leading to up-
staging of apparent stage I disease to stage IIIC. However, there
was greater morbidity, operating time and hospital cost with no
demonstrable overall survival advantage.
Prior test(s)
Serum CA125 and abdominal ultrasound are performed as part
of the RMI assessment. Women presenting with a pelvic mass and
a high RMI score will usually undergo a computed tomography
(CT) scan, magnetic resonance imaging (MRI) of the pelvis and
abdomen, or both to establish the extent of disease. Interpretation
of the histology slides at frozen section is made independently of
these prior tests, and so these bear no relevance to the diagnostic
accuracy of the frozen section test.
Role of index test(s)
Intraoperative frozen section analysis may allow appropriate selec-
tion of women with suspicious pelvic masses who would benefit
from optimal surgical staging.
Alternative test(s)
The ’gold standard’ for the diagnosis of ovarian cancer is
histopathological examination of surgical specimens by paraffin
section after laparotomy. In women not undergoing frozen sec-
tion, surgeons may choose to await paraffin section histology prior
to performing staging; to stage all women deemed to have a high
risk of malignancy; or to stage according to clinical suspicion, for
example by performing biopsy on peritoneal adhesions or sam-
pling enlarged lymph nodes.
Rationale
The importance of optimal surgical staging in ovarian cancer is
now well established. Frozen section analysis at diagnostic laparo-
tomy may allow the surgeon to accurately identify those women
with early stage ovarian cancer (who may otherwise not have been
identified during the initial procedure) who will benefit from
optimal surgical staging. This may avoid the need for a subse-
quent restaging procedure or adjuvant chemotherapy (Trimbos
2003).The role of intraoperative frozen section analysis in the di-
agnosis and management of early stage disease is particularly top-
ical at present, with many recent studies reporting high sensitivi-
ties and specificities for this diagnostic test. We decided to review
the evidence for and against frozen section as an accurate test to
diagnose early ovarian cancer.
O B J E C T I V E S
Primary objectives
To assess the diagnostic test accuracy of frozen section (index test)
in the histopathological diagnosis of ovarian cancer inwomenwith
suspicious pelvic masses as verified by paraffin section (reference
standard).
Within our review we aimed to establish the diagnostic accuracy
of frozen section in comparison to a reference standard diagnosis
of cancer from paraffin section, using measures of sensitivity and
specificity. There were two primary objectives.
1. To determine the accuracy of frozen section to identify cancer
cases, using a test threshold for frozen section that defines cancer
as a positive test result and considers both borderline and benign
results as test negative (Table 1). The rationale is that clinical and
surgical management is different where a case of malignancy is
identified.
2. To assess the accuracy of frozen section to identify cancer, using
a test threshold for frozen section that defines both cancer and
borderline cases as positive test results and considers benign results
as test negative (Table 2). The rationale is that the literature reports
a high rate of cases where the frozen section result was borderline,
but the final result from paraffin section was malignant. There are
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potentially serious repercussions from managing patients with a
cancer outside a cancer pathway when ’under staging’ occurs, that
is, if patients with malignancy do not receive surgical staging, in-
cluding lymphadenectomy. This is particularly relevant in women
found to have borderline ovarian masses at frozen section, as many
will receive a final paraffin section diagnosis of malignancy.
Which threshold is considered most useful in practice depends on
the clinicians’ judgement.
Secondary objectives
1. To establish if intraoperative frozen section analysis allows the
surgeon to accurately identify the cases of early stage ovarian cancer
that may benefit from optimal surgical staging.
2. To assess the accuracy of final diagnosis of malignancy, in a
subgroupofwomenwith a frozen section result of either borderline
or cancer. This corresponds to one strategy for referral for cancer
treatment.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included studies published in any language and, where possi-
ble, had non-English articles translated. We excluded studies that
involved ten or fewer patients.
Studies were eligible if:
1. Both frozen section analysis and paraffin section analysis
were performed in the same patient;
2. The absolute numbers of observations of true positives,
false positives, false negatives and true negatives were available or
derivable from the data reported in the primary studies.
We included both prospective and retrospective studies. However,
we excluded retrospective studies that collected data for a specific
histological type only, such as borderline tumours, due to the risk
of reporting bias.
We excluded studies in which frozen section analysis was per-
formed for conditions other than ovarian malignancy as well as
studies for which no English translation was available.
Participants
Women presenting to a secondary or tertiary care setting with
a pelvic mass suspicious of ovarian cancer, in whom physicians
employed frozen section analysis prior to paraffin section analysis.
Index tests
Intraoperative frozen section histopathological analysis. Test re-
sults were classified asmalignant, borderline or benign.We present
results using two different thresholds for the index test; malignant
vs borderline/benign, and malignant/borderline vs benign. The
reference standard remains diagnosis of malignancy in all analyses
in the review.
The diagnostically important distinction to make is between ma-
lignant/borderline and benign frozen section, because although
only women with malignant disease require surgical staging, stud-
ies have found the risks of borderline frozen section returning as
malignant to be high, and inadequately staging these women at
primary laparotomy may be deemed unacceptable (Cross 2012;
Puls 1997). However, many would argue that performing unnec-
essary staging on women with borderline disease confers unneces-
sary morbidity.
Target conditions
Ovarian malignancy, not obvious at a surgically or radiologically
advanced stage.
Reference standards
Paraffin section histopathological analysis. Test results are classi-
fied as malignant, borderline or benign. We present results using
the threshold for women classified as having ovarian cancer as ’ma-
lignant’ versus women not having cancer as ’borderline or benign’.
Search methods for identification of studies
Electronic searches
We identified eligible studies by searching the following electronic
databases.
• The Cochrane Gynaecological Cancer Group Specialised
Register January 2015.
• Cochrane Central Register of Controlled Trials
(CENTRAL),(2015, Issue 1).
• MEDLINE - Ovid (January 1946 to January 2015).
• EMBASE - Ovid (January 1980 to January 2015).
• Database of Abstracts of Reviews of Effects (DARE) (Issue
4, 2014).
• Health Technology Assessments (HTA) Database (Issue 4,
2014).
The MEDLINE search strategy included both subject headings
(MeSH terms) and text words for the target condition (ovarian
malignancy) and the histological technique under investigation
(’Frozen Section analysis’). We did not apply language restrictions.
We adapted the MEDLINE search to search CENTRAL, EM-
BASE, DARE and HTA databases. In particular, we adapted the
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MEDLINE MeSH terms into the corresponding terms available
in the EMTREE vocabulary. We present full details of the MED-
LINE and EMBASE search strategies, together with a brief sum-
mary of the MEDLINE search strategy, in Appendix 2. We im-
ported all citations identified by the MEDLINE and EMBASE
search strategies into an electronic database. We identified all po-
tentially eligible articles on PubMed and used the ’related articles’
feature to carry out a further search for newly published papers.
Searching other resources
Unpublished and grey literature
We searched for ongoing trials in the following trial registers and
contacted experts in the field to identify any further ongoing trials.
• metaRegister of Controlled Trials (mRCT) (http://
www.controlled-trials.com/mrct/).
• Physicians Data Query (PDQ) (http://www.cancer.gov/
cancertopics/pdq).
• ClinicalTrials.gov (http://clinicaltrials.gov/).
• National Cancer Institute (http://www.cancer.gov/
clinicaltrials/search).
Handsearching
We handsearched the citation lists of included studies, key text-
books and existing systematic reviews and checked their references.
When we retrieved relevant studies (even if we finally excluded
them), we also searched their references in order to minimise the
potential for missing relevant studies. We handsearched confer-
ence reports in the following sources.
• Gynecologic Oncology (Annual Meeting of the American
Society of Gynecologic Oncologists).
• International Journal of Gynecologic Cancer (Annual Meeting
of the International Gynecologic Cancer Society).
• British Gynaecological Cancer Society.
• European Society of Gynaecological Oncology.
• Society of Gynaecological Oncologists.
Data collection and analysis
Selection of studies
We downloaded all titles and abstracts retrieved by electronic
searching to Endnote and removed duplicates. Two authors (NR
and AP) independently examined the remaining reference titles
and abstracts to retrieve the full text of all potentially relevant re-
ports. Three authors (NR, AB and CF) independently reviewed
all relevant reports according to the pre-defined inclusion criteria
to determine eligibility. We resolved any disagreements through
arbitration by another author (RS), and we documented reasons
for exclusions.
Data extraction and management
One author (TL) designed and trialled a data extraction form
specifically to collect details from selected studies. Two authors
(NR and AB) recorded the relevant information for each individ-
ual study, without concealing the study authorship or publication
details. This information included: lead author, year of publica-
tion, accrual dates, country and setting, study design, method of
recruitment, setting, number and characteristics of participants,
any additional preoperative investigations performed, the refer-
ence standard used, any comparator tests used, follow-up, and in-
formation related to the pathologists interpreting the specimens
(background specialty, level of expertise). Two authors (NR and
AB) extracted data from the selected reports, and two authors (RS
and SM) checked the data extractions.
Assessment of methodological quality
Two review authors (NR and AB) independently assessed the
methodological quality of each included study using the re-
vised Quality Assessment of Diagnostic Accuracy Studies tool
(QUADAS-2) (Whiting 2011). We consulted a third author (RS)
in case of discrepancy between authors. The QUADAS-2 tool is
structured into a series of questions in four domains that should
be answered ’yes’, ’no’ or ’unclear’, and it aims to evaluate the
spectrum of bias. We resolved any disagreements by discussion.
Figure 4 is a graphic summary of the methodological quality of
included studies.
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Figure 4. Study flow diagram.
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We assessed the core QUADAS items in the following domains:
patient selection, index test, reference standard, flow and timing.
Patient selection
Could the selection of patients have introduced bias?
1. Was a consecutive or random sample of patients enrolled?
i) Yes; a study ideally should enrol a consecutive or
random sample of eligible patients with suspected disease to
prevent the potential for bias.
ii) No, a non-consecutive sample of patients was used.
iii) Unclear.
2. Was a case-control design avoided?
i) Yes; studies enrolling participants with known disease
and a control group without the condition may exaggerate
diagnostic accuracy.
ii) No.
iii) Unclear.
3. Did the study avoid inappropriate exclusions?
i) Yes; studies that make inappropriate exclusions (for
example, not including ’difficult-to-diagnose’ patients) may
result in overestimation of diagnostic accuracy.
ii) No.
iii) Unclear.
4. Were the patients selected representative of the patient
population the index test would apply to?
i) Yes; patients with a high risk of malignancy index
(RMI > 200) are usually the subjects who would benefit from
this index test.
ii) No; use of the index test in patients at low risk of
malignancy or in those with incidental finding at laparotomy for
other condition may bias the results.
iii) Unclear.
Index test
Could the conduct or interpretation of the index test have intro-
duced bias?
1. Were the index test results interpreted without knowledge
of the results of the reference standard?
i) Yes; knowledge of the reference standard may influence
interpretation of index test results. The potential for bias is
related to the subjectivity of interpreting index test and the order
of testing. If the index test is always conducted and interpreted
before the reference standard, this item can be rated ’yes’.
ii) No; if there was a previous histological diagnosis of
malignancy made during investigation of the same cyst, this item
can be rated ’no’.
iii) Unclear.
2. Were the index test results interpreted by a pathologist
specialising in gynaecological oncology?
i) Yes; specialist centres employing dedicated
gynaecological oncology pathologists may perform better in
interpreting frozen section slides and thereby improve the
sensitivity and specificity of the test.
ii) No.
iii) Unclear.
Reference standard
Could the reference standard, its conduct or its interpretation have
introduced bias?
1. Is the reference standard likely to correctly classify the target
condition?
i) Yes; estimates of test accuracy are based on the
assumptions that the reference standard is 100% sensitive and
that specific disagreements between the reference standard and
index test result from incorrect classification by the index test.
ii) No.
iii) Unclear.
2. Were the reference standard results interpreted without
knowledge of the results of the index test?
i) Yes; knowledge of the index test results may influence
interpretation of the reference standard results. Potential for bias
is related to the potential influence of previous knowledge on the
interpretation of the reference standard.
ii) No.
iii) Unclear.
Flow and timing
Could the patient flow have introduced bias?
1. Did all patients receive a reference standard, and if so did
they receive the same reference standard?
i) Yes; verification bias occurs when only a proportion of
the study group receives confirmation of the diagnosis by the
reference standard, or if some patients receive a different
reference standard. If the results of the index test influence the
decision on whether to perform the reference standard or which
reference standard is used, estimated diagnostic accuracy may be
biased. Accepted best practice is to verify all frozen section
diagnoses with paraffin section histology.
ii) No.
iii) Unclear.
2. Were all patients included in the analysis?
i) Yes; all participants recruited into the study should be
included in the analysis. A potential for bias exists if the number
of patients enrolled differs from the number of patients included
in the 2 x 2 table of results, because patients lost to follow-up
differ systematically from those who remain.
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ii) No.
iii) Unclear.
Statistical analysis and data synthesis
We entered data into Cochrane’s statistical software, Review
Manager 2014, to calculate sensitivity and specificity for each
study (we also present 95% confidence intervals of these point es-
timates in a forest plot). We present individual study results graph-
ically by plotting estimates of sensitivities and specificities in re-
ceiver operating characteristic (ROC) space. All studies reported
3 x 3 tables per patient enabling extraction of 2 x 2 tables from all
studies for three analyses of accuracy:
1. Reference test (paraffin test): positive result malignancy,
negative result borderline or benign. Index test (frozen section):
positive result malignancy, negative result borderline or benign
(Table 1).
2. Reference test: positive result malignancy, negative result
borderline or benign. Index test: positive result malignancy or
borderline, negative result benign (Table 2).
3. Subgroup analysis of malignant and borderline by index
test. Reference test: positive result malignancy, negative result
borderline or benign. Index test: positive result malignancy,
negative result borderline or benign.
We used xtmelogit commands in the Stata 13.1 statistical package (
Stata 2013) tometa-analyse pairs of sensitivity and specificity using
a bivariate random-effects approach (Reitsma 2005). The bivariate
approach was suitable for test results from 2 x 2 tables based on
categorical test thresholds. This approach enabled us to calculate
summary estimates of sensitivity and specificity, while correctly
dealing with any correlation that might exist between sensitivity
and specificity as well as the following sources of variation.
1. Imprecision in measurement of sensitivity and specificity
within each study.
2. Variation beyond chance in sensitivity and specificity
between studies.
We incorporated covariates in the bivariate model in order to ex-
amine the effect of potential sources of heterogeneity on sensi-
tivity and specificity. We used the results of the bivariate model
to calculate likelihood ratio tests in order to assess the statistical
significance of covariates.
Investigations of heterogeneity
We constructed a ROC plot of sensitivity versus 1 − specificity
and explored the heterogeneity of the sensitivity and specificity
estimates by examining both the ROC plot and forest plot.
In the protocol, we proposed to run a separate heterogeneity anal-
ysis for the following situations if there were sufficient studies re-
porting differences in these study characteristics.
• Preoperative investigation including a combination of
imaging and tumour markers (CA 125 +/- HE4).
• Preoperative imaging including CT or MRI scans.
• RMI score > 200.
• High risk study population, for example in a tertiary
referral centre.
• Size of ovarian cyst.
• Ovarian cyst histological type, for example mucinous or
serous.
• Expertise of pathologist reporting.
However, studies reported only two of these characteristics: ex-
pertise of reporting pathologist and whether there was a high risk
study population, for example, in a tertiary referral centre. All stud-
ies took place in university hospitals or tertiary referral centres, so
we could not examine for heterogeneity of study setting. We were
able to conduct a heterogeneity analysis for expertise of pathologist
reporting, for primary objective #1 and secondary objective #2,
although themodel did not converge in a heterogeneity analysis of
primary objective #2. For primary outcome #2, the model did not
converge, as there were only four studies in the less experienced
group, one of which was Toneva 2012, where specificity was low
(mostly likely due to small study size bias).Data extraction grouped
pathologist expertise into four categories as described in the stud-
ies (specialist gynaecological pathologist, consultant pathologist,
general pathologist or reader expertise not recorded). For hetero-
geneity analyses, we divided readers into more experienced (spe-
cialist gynaecological pathologist or consultant pathologist) and
less experienced/unknown expertise (general pathologist or reader
expertise not recorded). We conducted covariate analysis specify-
ing reader expertise as a covariate in STATA as recommended in
the Methods of the Cochrane Handbook for Diagnostic Test Accu-
racy Reviews (Macaskill 2010).
Sensitivity analyses
Wehadplanned sensitivity analyses for studieswithout verification
bias and those without missing data.
Assessment of reporting bias
We documented data regarding loss to follow-up and any loss of
data from pre-specified outcomes. As recommended in , we did
not conduct analyses to test for reporting bias (Macaskill 2010).
R E S U L T S
Results of the search
Results of the combined CENTRAL, MEDLINE, EMBASE,
DAREandHTA searches until January 2015 yielded 1657 records.
Four review authors (NR,AB,AP andCF) independently screened
and reviewed the titles and abstracts. Of these, 131 were selected
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for classification. Two authors (NR and AB) read the full-text ar-
ticles and assessed eligibility for the review. We discussed any dis-
pute with a third author (RS) (Figure 4). We excluded 93 studies
for the reasons summarised below. Some were excluded for more
than one reason.
• They were reviews, editorials, commentaries, case reports,
surveys, letters to the editor or conference abstracts (26).
• They were meta-analyses (2).
• An English translation was not available (6).
• We were unable to construct 2 x 2 tables from the results
(13).
• They were not studies using frozen section intraoperative
diagnosis (33).
• They reported only certain histologies (epithelial, serous or
mucinous) (11).
• They reported only borderline diagnoses (8); these studies
were not representative of the preselected population and did not
meet the inclusion criteria.
• They did not represent the population studied by this
review (20); these studies included predominantly benign
populations and populations in which evidence of extra-ovarian
spread was present at time of frozen section.
For further details see Characteristics of excluded studies.
We included 38 studies in 11,181 women. All studies evaluated
the index test of frozen section in comparison to the reference
standard of paraffin section.
Methodological quality of included studies
Of the 38 included studies, we considered 1 study to be at high
risk of bias (Wang 1998), and we had concerns regarding the ap-
plicability in 2 studies (Ilvan 2005; Wang 1998;). Wang 1998
reported outcomes of 792 consecutive gynaecological frozen sec-
tions, which included 299 samples from ovarian tissue, 360 sam-
ples from lymph nodes, 56 from uterine tissue and 77 samples
from other sites. The same pathologist reported the paraffin and
frozen sections. Ilvan 2005 reported making 7.5% of their frozen
section diagnoses on gross/macroscopic inspection alone. In fact,
grossly benign specimens were submitted in 46 cases. In some
cases, two experienced pathologists in gynaecological pathology
employed touch imprint methodology for diagnosis as well.
Overall, we found that the quality of the included studies was
acceptable with a low or unclear risk of bias (Figure 5; Figure 6).
However, we note that in many studies our assessment of risk
of bias was unclear; for example, it is not clear if pathologists
interpreted the reference test (paraffin) without knowledge of the
index test (frozen section), but this is unlikely to have introduced
bias in the diagnosis of ovarian cancer.
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Figure 5. Risk of bias and applicability concerns summary: review authors’ judgements about each domain
for each included study
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Figure 6. Risk of bias and applicability concerns graph: review authors’ judgements about each domain
presented as percentages across included studies
Types of studies
We included 38 retrospective studies. There were no case-control
studies. The sampling methods were consecutive in most studies
and unreported in the rest. All took place in university hospitals
or tertiary care settings (see Characteristics of included studies).
We excluded eight studies because we could not extract 2 x 2 tables;
these studies only included cases with borderline results by frozen
section.
The interest in borderline ovarian tumours at frozen section diag-
nosis arises from the fact that this diagnostic group is most likely
to see a change in diagnosis at paraffin section. This fact has been
attributed to various factors, namely ovarian histology, size of mass
and expertise of pathologist. In this review, two studies discussed
the ability of frozen section to predict malignancy depending on
histology (Cross 2012; Puls 1997). Puls 1997 included only serous
or mucinous ovarian masses, analysing the effect of weight on in-
terpretation of frozen section and reporting the greatest discor-
dance between frozen and paraffin section in frozen section-re-
ported borderline mucinous masses weighing over 1360g, with
50% (four out of eight) being upgraded to malignant at paraf-
fin section. Cross 2012 reported the majority of sampling errors
in serous and mucinous tumours, which accounted for 52.3% of
their 1439 ovarian masses submitted for frozen section. The false
negative rate for serous tumours was 0.7% and for mucinous tu-
mours 3.8%. Furthermore, 47.2% of all borderline tumours were
reclassified as malignant on paraffin section, and these were evenly
distributed amongst the serous and mucinous categories.
Patient selection
We considered participants in the included studies to be represen-
tative of patients receiving the index test in clinical practice. The
majority of studies reported women with pelvic masses, although
none provided information regarding tumour markers, such as
CA125, or preoperative imaging.
Index test methods
All patients in the included studies received the index test, namely
frozen section, and a number of studies provided details of frozen
sectioning. Typically, this involved taking between 1 and 7 sections
from the ovarian mass, cut into 5 µm thick frozen sections.
Pathologists of varying expertise performed analyses of the
frozen section: specialist gynaecological pathologist (6), consultant
pathologist (8) or general pathologist (4); studies did not record
expertise in 20 cases.
Several studies reported ’deferred’ or unclear diagnoses at frozen
section, where the pathologist was unable to make a diagnosis
on the submitted material. We excluded these results from 3 x 3
tables. Pathologists may defer diagnosis to paraffin section for 3
reasons: not enough tissue is submitted for analysis; the pathologist
is unable to make a diagnosis; or there are technical issues.
Reference standard methods
All patients received the reference standard, namely paraffin sec-
tion. In three studies (Puls 1997;Wang 1998; Yeo 1998), the same
pathologist interpreted the paraffin section and the frozen section.
The other included studies did not mention whether they em-
ployed the same pathologist to interpret both index and reference
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standard tests. No studies reported blinding of pathologists to in-
dex test results when reporting paraffin sections. There were no bi-
ases with flow or timing, as paraffin section was always performed
after frozen section, with both tests conducted on samples taken
at the same time.
Flow and timing
All patients who received frozen section then received paraffin
section. There was no bias in flow or timing amongst included
studies. The only potential source of bias was interpretation of
both reference and index tests by the same reporting pathologist,
as indicated in the studies of Puls 1997,Wang 1998 and Yeo 1998.
In clinical practice, it is likely that most surgeons, at the time of
submitting the surgical specimen for paraffin section, will indicate
to the pathologist that a frozen section has already been performed
and detail the results of the frozen section. As blinding from this
has not been reported in any of the included studies, it is entirely
reasonable to believe that pathologists were aware of the frozen
section results when interpreting the paraffin section.
Paraffin section analysis was performed on the same submitted
mass as the frozen section, and therefore time interval to paraffin
section was not an issue, as there was no risk of disease progression
between tests.
Investigations of heterogeneity
Unfortunately, only one study gave adequate information about
histology of all frozen sections performed (Cross 2012). Puls
1997 gave enough information for 2 x 2 tables to be constructed
for serous, mucinous and endometrioid tumours only. We were
therefore unable to perform a heterogeneity analysis according to
histopathological type.
None of the included studies provided sufficient information re-
garding preoperative investigations or imaging, RMI value, or size
of mass to conduct heterogeneity analyses.
We investigated variability between studies to establish whether
levels of expertise of pathologists reading the frozen section results
could explain heterogeneity between studies. We found that there
was no statistically significant difference between studies with dif-
ferent levels of expertise of pathologists in primary outcome #1
and secondary outcome #2. For primary outcome #2, the model
did not converge, as there were only four studies in the less expe-
rienced group, one of which was Toneva 2012, where specificity
was low (mostly likely due to small study size bias). The lack of
heterogeneity due to expertise of pathologists may be due to the
fact that the included studies originated from university hospitals
or tertiary centres.
Sensitivity analyses
We did not conduct sensitivity analyses, as all studies excluded
verification bias. A sensitivity analysis based on missing data will
be included in a review update, but we note there was only a small
amount of missing data.
Findings
Thirty-eight studies were suitable for addressing the review ob-
jectives, as we were able to extract 3 x 3 tables from all studies
based on thresholds of cancer, borderline and benign for both
frozen and paraffin section results. There were a total of 169 de-
ferred diagnoses excluded from 11,350 cases (1.5% of all cases),
leaving 11,181 cases for analysis. Unfortunately, only one study
commented on surgical staging with regard to frozen section, and
therefore we could not perform an analysis to address secondary
objective #1 (Naik 2006). The results addressing the two primary
objectives and secondary objective #2 are detailed below. We sum-
marise these results in the Summary of findings, giving different
examples of pre-test prevalences of malignancy to allow clinicians
to infer the relevance of the data according to their population.
Primary objective #1: accuracy of frozen section
cancer results to identify women with cancer
Sensitivity and specificity results were available from 38 studies
involving 11,181 participants (3200 identified with cancer, 1055
as borderline and 6926 as benign by paraffin section reference
standard). We used a test threshold for frozen sections to define
cancer as a positive test result and borderline and benign results as
negative test results. The prevalence of cancer ranged from 11% to
63%. The average sensitivity was 90.0% (95% confidence interval
(CI) 87.6% to 92.0%; typical range 71% to 100%, with one
small study, García 1997, reporting it as 64%), and the average
specificity was 99.5% (95% CI 99.2% to 99.7%: range 96% to
100%).
Figure 7 is a forest plot of sensitivity and specificity with 95%
confidence intervals for all studies, ordered by the percentage of
cancer cases, that is, disease positive (DP) in each study to give
insight into the representativeness of the study. Figure 8 shows
the results from all studies in a ROC plot. Both figures show that
the data are homogeneous enough to combine by meta-analysis
and give summary estimates. The average sensitivity was 90.0%
(95% CI 87.6% to 92.0%; range 64% to 100%), and the average
specificity was 99.5% (95% CI 99.2% to 99.7%: range 96% to
100%). Results for specificity were more homogenous than for
sensitivity, where we have ordered studies in the forest plot by the
number of cancer cases. Studies with small numbers of cancer cases
have wider confidence intervals for sensitivity, and study estimates
are likely to be less reliable. This is particularly pertinent for García
1997, with 11 cancer cases.
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Figure 7. Forest plot: frozen section threshold malignant vs borderline or benign
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Figure 8. Summary ROC plot of 1 frozen section: threshold malignancy vs borderline or benign
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We completed a pre-specified analysis of heterogeneity based on
pathologist reader expertise, defining four reader groups that we
then grouped into two categories to enable analysis to have a suf-
ficient number of studies in each group: more specialised (consul-
tant, and specialist gynaecological pathologist) and other (general
pathologist or expertise not reported). Figure 8 shows the expertise
of pathologists for each study using different symbols. Statistical
analysis did not show a statistically significant difference in sensi-
tivity and specificity based on reader expertise.
Primary objective #2: accuracy of frozen section
cancer or borderline results to identify women with
cancer
Sensitivity and specificity results were available from the same 38
studies using the test threshold for frozen section where we con-
sidered both cancer and borderline cases to be positive and benign
cases to be negative. The average sensitivity was 96.5% (95% CI
95.5% to 97.3%; typical range 83% to 100%, with one very small
study, García 1997, reporting a sensitivity of 0%) and the average
specificity was 89.5% (95% CI 86.6% to 91.9%: typical range
58% to 99%, with one study, Gorisek 2009, reporting a speci-
ficity of 29%). Results were reasonably homogeneous except for
differences likely to be due to small sample sizes.
Figure 9 is a forest plot of sensitivity and specificity with 95%
confidence intervals for all studies, ordered by the number of dis-
ease negative cases (DN = benign) with the studies reporting the
largest numbers of benign cases at the top. In addition, we show
the percentage of cancer, borderline and benign in each study to
give insight into the representativeness of the study. The percent-
age of borderline cases is likely to influence the specificity results,
as many of these cases are not found to be malignant by the refer-
ence test of paraffin section. This is well demonstrated by Gorisek
2009, with only 2% of benign cases, where specificity is reduced
due to the high proportion of borderline cases in the study popu-
lation.
Figure 9. Forest plot: frozen section threshold malignant or borderline vs benign
Figure 10 shows the results from all studies in a ROC plot.
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Figure 10. Summary ROC plot of 2 frozen section: threshold malignancy or borderline vs benign
Both figures show that sensitivity is reasonably homogeneous, but
as expected, specificity is more variable in studies with a relatively
high percentage of borderline cases and a low number of disease
negative (i.e. benign) cases (García 1997; Gorisek 2009; Kokka
2009; Toneva 2012). We have used bivariate meta-analysis to ob-
tain estimates for both average sensitivity and average specificity,
as there are a reasonable number of studies. The average sensitiv-
ity was 96.5% (95% CI 95.5% to 97.3%; typical range 83% to
100%, with one very small study, García 1997, reporting a sen-
sitivity of 0%), and the average specificity was 89.5% (95% CI
86.6% to 91.9%: typical range 58 to 99, with one study, Gorisek
2009, reporting a specificity of 29%).
We attempted a pre-specified analysis of heterogeneity based on
reader expertise, but models did not converge.
Secondary objective #2: accuracy of final diagnosis of
malignancy in women with a frozen section result of
either borderline or cancer
Sensitivity and specificity results were available from the same 38
studies, including the subset of 3953 participants with a frozen
section result of either borderline or invasive cancer, based on the
accuracy of referral for cancermanagement, that is, surgical staging
22Intraoperative frozen section analysis for the diagnosis of early stage ovarian cancer in suspicious pelvic masses (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
in invasive cancer.
Figure 11 is a forest plot of sensitivity and specificity with 95%
confidence intervals for all studies, ordered by the number of bor-
derline cases in each study, with the studies reporting the highest
number of borderline cases shown at the top.
Figure 11. Forest plot: frozen section malignant or borderline only. Threshold malignant
Studies with small numbers of disease negative cases (borderline
cases) at the bottom of the plot have more variation in estimates
of specificity, most likely due to small numbers in a study, likely
overriding any other potential sources of bias in these studies.
We include the percentage of malignant cancer in these patients
with frozen section results of either cancer or borderline to aid
understanding of how studies may compare to other centres. The
percentage of borderline cases is likely to influence the specificity
results, as many of these cases are not malignant according to the
reference test of paraffin section. Figure 12 shows the results from
all studies in a ROC plot.
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Figure 12. Figure 8 (Analysis 3)
Both figures show that sensitivity and specificity are more het-
erogeneous than other analyses. Results from studies with low
numbers of borderline cases are particularly heterogeneous due
to small sample sizes of two, five and seven borderline cases (in
Torres 1998, Maheshwari 2006 and Yarandi 2008, respectively).
We used bivariate meta-analysis to obtain estimates both for av-
erage sensitivity and average specificity, as there were a reasonable
number of studies. The average sensitivity was 94.0% (95% CI
92.0% to 95.5%; range 73% to 100%), and the average speci-
ficity was 95.8% (95% CI 92.4% to 97.8%: typical range 81% to
100%, with three outlier studies, Torres 1998, Yarandi 2008 and
Maheshwari 2006, showing specificities of 0% , 40% and 71%,
respectively).
Figure 13 presents the reference standard result for all studies for
frozen section diagnoses of either cancer or borderline. Across all
studies, an average of 81% of results were malignant by the ref-
erence standard (median 81%, interquartile range (IQR) 78% to
84%), 17% were borderline (IQR 14% to 21%) and 2% were
benign (IQR 2% to 5%).
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Figure 13. Frozen section result malignant or borderline: final diagnosis by reference standard
Additional analyses
Figure 14, Figure 15 and Figure 16 provide a breakdown of frozen
section results by postsurgical reference standard for benign, cancer
and borderline results, respectively, to provide additional insight
on the correspondence between test results. This provides further
information to help understand how frozen section results were
updated following postsurgical paraffin section confirmation in
our included studies.
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Figure 14. Frozen section result benign: final diagnosis by reference standard
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Figure 15. Frozen section result malignant: final diagnosis by reference standard
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Figure 16. Frozen section result borderline: final diagnosis by reference standard
On average, 94% (IQR 92% to 96%) of benign diagnoses from
frozen section were found to be benign on paraffin section.
On average, 99% (IQR 98% to 100%) of cancer results from
frozen section were found to be cancerous on paraffin section.
However, for borderline results from frozen section, on average
only 73%(IQR63%to78%) remainedborderline, but 21% (IQR
14% to 26%) were upgraded to cancer, and 6% (IQR 2 to 8%)
were downgraded to benign.
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Summary of findings
Review question: to establish the accuracy and other diagnostic parameters (sensitivity and specificity) of intraoperative frozen section analysis in the histopathological diagnosis of ovarian
cancer, in comparison to paraffin section reporting
Patients/population: women presenting to a secondary or tertiary care setting with a pelvic mass suspicious of ovarian cancer, in whom frozen section analysis was employed prior to
paraffin section analysis
Role: intraoperative diagnosis of ovarian mass to guide surgery
Index tests: intraoperative frozen section histopathological analysis
Reference standards: paraffin section histopathological analysis
Studies: retrospective cohort; no prospective cohort studies identified
Clinical setting: any clinical setting. In this review, all included studies took place in university hospitals or tertiary centres
Frozen section test Effect (96% CI) No of participants, DP
(studies)
Test result Number of results per 1000 participants testeda
(95% CI)
Prevalence of malignancy in all patients (where frozen section is used)
Prevalence
23%
Prevalence 29% Prevalence 36%
Primary objective #1:
Frozen section: malignant
versus borderline/benign
All patients (8% border-
line)
Sensitivity 90.0
(87.6 to 92.0)
Specificity 99.5
(99.2 to 99.7)
11,181, 3200 (38) True positives
False negatives
False positives
True negatives
207 (201 to 212)
23 (18 to 29)
4 (2 to 6)
766 (764 to 768)
261 (254 to 267)
29 (23 to 36)
4 (2 to 6)
706 (704 to 708)
324 (315 to 331)
36 (29 to 45)
3 (2 to 5)
637 (635 to 638)
Primary objective #2:
Frozen section: ma-
lignant/borderline versus
benign
All patients (8% border-
line)
Sensitivity 96.5 (95.5 to
97.3)
Specificity 89.5 (86.6 to
91.9)
11,181, 3200 (38) True positives
False negatives
False positives
True negatives
222 (220 to 224)
8 (6 to 10)
81 (62 to 103)
689 (667 to 708)
280 (277 to 282)
10 (8 to 13)
75 (58 to 95)
635 (615 to 652)
347 (344 to 350)
13 (10 to 16)
67 (52 to 86)
573 (554 to 588)
Prevalence of malignancy in subgroup of patients with frozen section
malignant/borderlineb
Prevalence 75% Prevalence 80% Prevalence 86%
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Secondary objective #2:
Frozen section: malignant
versus borderline/benign
in subgroup of patients
with frozen section result
malignant/borderline
Sensitivity 94.0 (92.0 to
95.5)
Specificity 95.8 (92.4 to
97.8)
3953, 3084 (38) True positives
False negatives
False positives
True negatives
705 (690 to 716)
45 (34 to 60)
11 (6 to 19)
240 (231 to 245)
752 ( 736 to 764)
48 (36 to 64)
8 (4 to 15)
192 (185 to 196)
808 (791 to 821)
52 (39 to 69)
6 (3 to 11)
134 (129 to 137)
Attributes of tests contributing to benefits and risks
Frozen section Intraoperative frozen section enables surgeons to perform surgical staging appropriately in patients with frozen section diagnosis of ovarian malignancy, thereby
reducing the need for a second surgical procedure. If surgical staging confirms there is no extra ovarian disease, chemotherapy may not be required
Other benefits of frozen section include diagnosis of tumour origin and diagnosis of metastatic disease
Risks of frozen section relate to overstaging/overtreatment for malignancy in false positives
Overall quality of evidence/risk of bias:
Patient selection: included studies are retrospective. The majority report consecutive cases, but in several the sampling is unclear
Index test: deferred and unclear frozen section results reported and excluded from 3 x 3 tables
Reference standard: Pathologists must have been aware of frozen section results at time of performing paraffin section. Four studies reported the same pathologist interpreting both tests
Flow and timing: paraffin section takes place after frozen section so no bias in timing
Precision: Average estimates of both sensitivity and specificity have good precision
CI: confidence interval; DP: disease positive.
aPrevalence of malignancy from included studies. median, lower and upper interquartile range values of 23%, 29% and 36% respectively.
bPrevalence of malignancy from included studies from subgroup of cases where frozen section of malignant or borderline may be used
to refer to cancer surgery: median, lower and upper interquartile range values of 75%, 80% and 86% respectively.
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D I S C U S S I O N
Summary of main results
We report the largest review of frozen section accuracy in ovarian
masses to date, with a median prevalence of 29% cancers (IQR
23% to 36%) across the included studies. In the Summary of
findings we have provided examples of prevalence of malignancy
to help clinicians to interpret presented results and inform their
practice. Accuracy results were relatively consistent between stud-
ies, except for studies with small numbers of cases. All studies were
retrospective, with the majority reporting consecutive cases. We
excluded deferred and unclear frozen section results from analysis.
We expect that reference standard interpretation was not blinded
to frozen section results.
In a hypothetical study of 1000 patients, of whom 290 had cancer
and 80 were borderline, on average 261 women (95% CI 254
to 267) would receive a correct diagnosis of cancer based on a
frozen section result of cancer, and 706 women (95% CI 704 to
708) would be correctly diagnosed without cancer. However, on
average 4 women (95% CI 2 to 6) would be incorrectly diagnosed
as having a cancer (false positive), and 29 women (95% CI 23
to 36) with cancer would be missed at the time of surgery (false
negative).
Likewise, in a hypothetical population of 1000 women, of whom
290 had cancer and 80 were borderline, based on a frozen section
result of either cancer or borderline to diagnose cancer, on average
280 women (95% CI 277 to 282) would be correctly diagnosed
with a cancer and correctly receive surgical staging. Six hundred
and thirty-five women (95% CI 615 to 652) would be correctly
diagnosed without cancer. However, on average 75 women (95%
CI 58 to 95) would be incorrectly diagnosed as having a cancer
on frozen section and would be over treated with surgical staging.
Ten women (95% CI 8 to 13) with cancer would be missed at the
time of surgery and might require a second surgical procedure for
staging.
Our additional analyses showed that if the frozen section was be-
nign or cancerous, then the final diagnosis would remain the same
in, on average, 94% and 99% of cases, respectively (Figure 14;
Figure 15).
In cases where the frozen section diagnosis was borderline, there
is a chance that the final diagnosis would turn out to be cancer in,
on average, 21% of women (Figure 16).
On investigating the factors that could lead to variability between
studies, we found that there was no difference in diagnostic ac-
curacy between levels of expertise of pathologists. In cases where
there was a discordance between frozen section and paraffin sec-
tion, most studies tabulated reasons for discordance that fell into
one of two categories: tissue sampling error (where the sampled
portions of the mass failed to give the paraffin section diagnosis);
or interpretation error (where the pathologist incorrectly reported
the frozen section samples). Tissue sampling error was more com-
monly reported in borderline frozen section diagnoses.
Strengths and weaknesses of the review
Strengths
This review presents a meticulous analysis of existing literature
and interprets the data with presentation of clinical relevance. By
applying previously defined, clear criteria for eligibility, we aimed
to minimise heterogeneity in included studies. We excluded stud-
ies that did not represent the population in which frozen section
might be used to assess suspicious ovarian masses. We assessed
methodological quality and risk of bias. Although several studies
had small sample sizes, the number of studies included in the re-
view (N = 38) and the number of patients (N = 11,181) increased
the power of the meta-analyses.
Analysis of the data by varying the test positive response (’malig-
nant’; and ’malignant and borderline’) facilitates interpretation of
the test data to guide surgical management. Specifically, the pooled
analysis of borderline cases compared to test positive malignant
cases provides valuable information to aid not only intraopera-
tive decision-making but also perioperative counselling of patients
about likely outcomes.
Weaknesses
There are three weaknesses regarding pathology reporting within
this review. Firstly, although this review addresses the effect of
pathologist expertise on frozen section interpretation, all included
studies were conducted in university hospitals or tertiary centres,
which may introduce a reporting bias within this review. Secondly,
given that no studies reported pathologist blinding, we have to
assume that all included studies in this review were unblinded.
The extent of bias is somewhat limited given the flow and timing
of the tests, in that the index test always precedes the reference
standard. The implications of unblinded testing might potentially
mean that a pathologist reporting the paraffin section would be
more likely to agree with the frozen section, especially if it is the
same pathologist reporting both. However,in clinical practice the
Pathology department usually receives the result of the frozen sec-
tion as part of required clinical information in submitting tissue
for histological processing. Thirdly, the criteria used for diagnosis
of borderline ovarian tumours varies internationally. The included
studies did not report the criteria used.
Very few studies reported the use of preoperative imaging or tu-
mour markers. It was therefore difficult to make inferences about
these variables.
Applicability of findings to the review question
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Frozen section is a useful tool in aiding intraoperativemanagement
of suspicious ovarian masses. This review finds that if the frozen
section is benign or cancerous, the paraffin section will be concor-
dant in 94% and 99% of cases, respectively. In these groups there
is a high likelihood patients will receive the appropriate surgery
based on frozen section results, as indicated by Naik 2006, thereby
avoiding unnecessary staging in those with benign histology ac-
cording to paraffin section and without compromising those with
true stage I ovarian cancer. Lawrie 2015 demonstrated in a sub-
group analysis of three trials that, at a median follow-up of 5 years,
there was no apparent additional benefit to overall survival from
adjuvant chemotherapy in the group that was optimally staged
(Bolis 1995; ICON 1; Trimbos 2003). However, they had con-
cerns about selective reporting of the 10-year survival data and
performed an exploratory analysis of ’deaths from ovarian cancer’
at 10 years. This analysis suggested that “the difference between
subgroups (optimally versus suboptimally staged) in deaths from
ovarian cancer was not statistically significant (test for subgroup
differences: Chi2 test = 2.75, degrees of freedom (df ) = 1, P = 0.10;
I2 statistic = 63.6%)”.
The prevalence of cancer in a referred population is particularly
relevant for borderline ovarian tumours given the degree of dis-
cordance with paraffin section diagnosis. In this review, with an
average prevalence of cancer of 29%, the chance of a patient with a
borderline tumour being appropriately treated with surgical stag-
ing is 21%. This would in turn mean that, should all women with
borderline frozen section undergo a surgical staging procedure in-
cluding hysterectomy, pelvic +/- paraaortic lymphadenectomy and
omentectomy, 79% of them would be over treated. This confers
unnecessary risk of morbidity, which includes lymphoedema, lym-
phocyst formation, visceral and neurovascular injury. The benefit,
however, is a reduction in morbidity associated with a second sur-
gical procedure should low-risk ovarian cancer be diagnosed on
paraffin section.
In their interpretation of this review, readers should evaluate the
presented results by comparing the prevalence of test positive (can-
cer) in their population to examples provided in the Summary of
findings. The clinicopathological considerations to be taken into
account when using frozen section include the following: women
with high-risk disease will require adjuvant platinum-based che-
motherapy; optimal staging in true stage I disease confers prog-
nostic benefit; staging will detect stage III disease in a quarter of
women who will require dual agent chemotherapy; and women
need to be well counselled regarding the risks of over treatment
and under treatment if physicians rely on frozen section results.
In addition, although outside the scope of this review, the clinical
benefits of frozen section analysis include the ability to diagnose
metastatic disease and, in some cases, site of origin. This may
lead to better exploration of other organs at laparotomy for site of
primary tumour and avoid unnecessary surgical staging in non-
ovarian malignancy.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Frozen section testing of ovarian masses can be used intraopera-
tively in gynaecological cancer centres for investigation of women
with ovarian masses suspected to be early-stage malignancy. In
practice, use of frozen section depends on a number of factors.
• The clinical suspicion of cancer. This is usually reflected by
the prevalence of cancer within a referred population, that is, a
tertiary centre will report higher rates of cancer than a secondary
centre. Women undergoing the index test can be counselled
about the advantages and disadvantages of undergoing surgical
staging if the frozen section result is borderline.
• The expertise of the gynaecologist to perform a surgical
staging procedure should the frozen section result prove to be
cancer. The value of the index test depends on the ability of the
surgeon to appropriately manage the case.
• The ability of the pathologist to interpret frozen sections
and for histopathology departments to provide the frozen section
service.
Implications for research
The largest discordance is within the reporting of frozen section
borderline tumours. The authors would encourage future publica-
tions to include all reported frozen section results and their histo-
logical subtypes so that further subgroup analyses on the border-
line population can be performed to minimise reporting bias and
heterogeneity analyses can be performed on histological subtypes.
Investigation into factors leading to discordance within centres
and standardisation of criteria for reporting borderline tumours
may help further improve accuracy.
Further research is also warranted, perhaps in the form of a ran-
domised clinical trial, to evaluate the oncological and surgical out-
comes from surgical staging in cases of apparent stage I ovarian
cancer. This would help establish whether there is a place for frozen
section analysis in gynaecological cancer centres and further in-
form clinical practice by addressing not only survival but also mor-
bidity associated with under- and over-staging in the borderline
population.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Açikalin 2014
Study characteristics
Patient sampling Design: Retrospective
Setting: Turkey
Accrual dates: July 2006 - January 2013
No participants: 282
No assessed: 282
Inclusion criteria: Re-analysis of charts of 282 women with an ovarian neoplasm (42.8% of all gy-
naecologic FSs) with intraoperative FS reports. Paraffin section diagnoses with non-tumoural ovar-
ian lesions (massive ovarian edema, hemorrhagic necrosis, benign cysts, infections) were excluded.
Included previous histological diagnosis: unclear
Patient characteristics and set-
ting
Excluded non-tumoral ovarian masses
Index tests “All fresh gross specimenwere examined by a resident and a pathologist or particularly gynecopathol-
ogist, in terms of localization, size, colour, content, heterogeneity, infiltration pattern of the tumour
and condition of the ovarian capsule. One to four sections depending on the size and heterogeneity
of the tumour were sampled in a cryostat and sections were stained by hematoxylin-eosin. Slides
were evaluated and reported to the surgeon by the pathologist. Final PS diagnosis reported by an
experienced gynecopathologist was accepted as accurate diagnose.”
Target condition and reference
standard(s)
Malignancy; paraffin section
Flow and timing FS before PS.
Comparative
Notes Re-analysis of charts of 282 women with an ovarian neoplasm (42.8% of all gynaecologic FSs) with
intraoperative FS reports diagnosed between July 2006 and January 2013. Paraffin section diagnoses
with non-tumoural ovarian lesions (massive ovarian edema, hemorrhagic necrosis, benign cysts,
infections) were excluded
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
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Açikalin 2014 (Continued)
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Was the sample representative
of patients in practice (90%
stage I/II with RMI>200)?
Unclear
Unclear
DOMAIN 2: Index Test All tests
Were the index tests interpreted
without knowledge of the refer-
ence standard?
Yes
Were the index tests Interpreted
by consultant or specialist gyn-
onc pathologist?
Unclear
Unclear
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear
DOMAIN 4: Flow and Timing
Did all patients receive a refer-
ence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were un-interpretable/inter-
mediate test results reported?
Yes
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Açikalin 2014 (Continued)
Were withdrawals from the
study explained?
Yes
Bazot 2006
Study characteristics
Patient sampling Design: Retrospective
Setting: France
Accrual dates: Jan 1999 - Dec 2003
No participants: 136
No assessed: 151*
Inclusion criteria: Complex / suspicious adnexal masses referred for pre-op MRI
Included previous histological diagnosis: unclear
Patient characteristics and set-
ting
Complex / suspicious adnexal masses referred for pre-op MRI. France
Index tests FS prepared from vegetations in cyst walls or solid areas selected by macroscopic exam
Target condition and reference
standard(s)
Malignant or borderline on paraffin section.
Flow and timing FS before PS.
Comparative
Notes Compares accuracy of pre-op MRI and FS. * 136 women, 32 with bilateral masses (15 bilateral and
17 unilateral FS) - total 151 FS analyses included
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
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Bazot 2006 (Continued)
Was the sample representative
of patients in practice (90%
stage I/II with RMI>200)?
Unclear
Unclear
DOMAIN 2: Index Test All tests
Were the index tests interpreted
without knowledge of the refer-
ence standard?
Yes
Were the index tests Interpreted
by consultant or specialist gyn-
onc pathologist?
Unclear
Unclear
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Did all patients receive a refer-
ence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were un-interpretable/inter-
mediate test results reported?
No
Were withdrawals from the
study explained?
No
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Bige 2011
Study characteristics
Patient sampling Design: Retrospective
Setting: Turkey
Accrual dates: Jan 2002 - Dec 2010
No participants: 578
No assessed: 519
Inclusion criteria: Indications for FS - radiologically or macroscopically benign appearing ovarian
masses with high CA125, history of malignancy other than ovary and fertility preserving surgery
for young cases. 59 exclusions - 14 definitive diagnosis not obtained by FS, 23 no ovarian tissue
identified in masses, 22 metastases to ovaries
Included previous histological diagnosis: unclear
Patient characteristics and set-
ting
University hospital in Turkey
Index tests 2-5 sections esp from solid areas, examined by at least 2 consultant pathologists (gynae 83.2%, non-
gynae 16.8%)
Target condition and reference
standard(s)
Malignant or borderline disease; paraffin section
Flow and timing PS performed after FS. 59 patients excluded: in 14, definitive diagnosis could not be obtained at
FS; in 23, no ovarian tissue identified in masses; in 22, metastases to ovary
Comparative
Notes FS reported by at least 2 consultant pathologists (gynae pathologists 83.2%, non-gynae 16.8%).
Unclear if same pathologists reported PS or if FS results masked. Possible interpretation bias
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Was the sample representative
of patients in practice (90%
stage I/II with RMI>200)?
Unclear
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Bige 2011 (Continued)
High
DOMAIN 2: Index Test All tests
Were the index tests interpreted
without knowledge of the refer-
ence standard?
Yes
Were the index tests Interpreted
by consultant or specialist gyn-
onc pathologist?
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Did all patients receive a refer-
ence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were un-interpretable/inter-
mediate test results reported?
Yes
Were withdrawals from the
study explained?
Yes
46Intraoperative frozen section analysis for the diagnosis of early stage ovarian cancer in suspicious pelvic masses (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Boriboonhirunsarn 2004
Study characteristics
Patient sampling Design: Prospective diagnostic test accuracy
Setting: Thailand
Accrual dates: July 2001 to March 2002
No participants: 147
No assessed: 147
Inclusion criteria: Included women with ovarian tumours for surgery. Excluded if give prior treat-
ment for cancer (radiotherapy or chemotherapy).
Included previous histological diagnosis: NR
Patient characteristics and set-
ting
Included women with ovarian tumours for surgery. Excluded if give prior treatment for cancer
(radiotherapy or chemotherapy).Thailand
Index tests Number of slides and area to be sectioned were determined by one experienced pathologist, who
also examined and interpreted all slides, ’Slides were interpreted without knowledge of the results
of those prepared by the other technique’
Target condition and reference
standard(s)
Malignant or borderline on PS.
Flow and timing FS before PS.
Comparative
Notes Surgical extent not reported.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Was the sample representative
of patients in practice (90%
stage I/II with RMI>200)?
Unclear
Unclear
DOMAIN 2: Index Test All tests
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Boriboonhirunsarn 2004 (Continued)
Were the index tests interpreted
without knowledge of the refer-
ence standard?
Yes
Were the index tests Interpreted
by consultant or specialist gyn-
onc pathologist?
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Did all patients receive a refer-
ence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were un-interpretable/inter-
mediate test results reported?
Yes
Were withdrawals from the
study explained?
Unclear
Canis 2004
Study characteristics
Patient sampling Design: Retrospective
Setting: Canada
Accrual dates: 5 years
No participants: 141
No assessed: 141
Inclusion criteria: All women undergoing laparoscopy in order to treat ovarian or paraovarian tu-
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Canis 2004 (Continued)
mours. Excluded obvious malignancy and benign massses (uterine, peritoneal cysts, hydrosalpinges)
.
Included previous histological diagnosis: unclear
Patient characteristics and set-
ting
Macroscopically suspicious ovarian tumours. Large tertiary care centre
Index tests Details not reported
Target condition and reference
standard(s)
Malignant or borderline disease
Flow and timing FS before PS.
Comparative
Notes Laparoscopic management with staging procedure to FS (borderline or malignant) by either la-
paroscopy or laparotomy
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Was the sample representative
of patients in practice (90%
stage I/II with RMI>200)?
Yes
Low
DOMAIN 2: Index Test All tests
Were the index tests interpreted
without knowledge of the refer-
ence standard?
Yes
Were the index tests Interpreted
by consultant or specialist gyn-
onc pathologist?
Unclear
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Canis 2004 (Continued)
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Did all patients receive a refer-
ence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were un-interpretable/inter-
mediate test results reported?
Yes
Were withdrawals from the
study explained?
No
Cross 2012
Study characteristics
Patient sampling Design: Prospective diagnostic test accuracy
Setting: UK
Accrual dates: Jan 2000 to Dec 2010
No participants: 1445
No assessed: 1439
Inclusion criteria: Women with possible ovarian malignancy were included. Women with obvious
disseminated malignancy (FIGO stage III/IV) were excluded.
Included previous histological diagnosis: yes, 6 cases
Patient characteristics and set-
ting
Women with possible ovarian malignancy were included. Women with obvious disseminated ma-
lignancy (FIGO stage III/IV) were excluded.Tertiary centre, UK
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Cross 2012 (Continued)
Index tests Two pieces of tissue taken for FS staining and reporting by consultant pathologist. Report was then
phoned through to surgeon who used the info to determine the extent of surgery
Target condition and reference
standard(s)
Malignant or borderline on PS.
Flow and timing FS before PS.
Comparative
Notes Women with borderline and malignant diagnosis underwent surgical staging
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Was the sample representative
of patients in practice (90%
stage I/II with RMI>200)?
Yes
Low
DOMAIN 2: Index Test All tests
Were the index tests interpreted
without knowledge of the refer-
ence standard?
Yes
Were the index tests Interpreted
by consultant or specialist gyn-
onc pathologist?
Yes
Low
DOMAIN 3: Reference Standard
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Cross 2012 (Continued)
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Did all patients receive a refer-
ence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were un-interpretable/inter-
mediate test results reported?
Yes
Were withdrawals from the
study explained?
Yes
Cuello 1999
Study characteristics
Patient sampling Design: Retrospective
Setting: Chile
Accrual dates: Jan 1988-Oct 1998
No participants: 842
No assessed: 489
Inclusion criteria: Ovarian masses. 2x2 data available only for epithelial ovarian masses.
Included previous histological diagnosis: unclear
Patient characteristics and set-
ting
Epithelial ovarian masses. Chile.
Index tests Sections were taken every 3-4cm, measuring 2-3mm. Frozen sections measuring 5microns were
taken
Target condition and reference
standard(s)
Malignant or borderline on PS. 2 x 2 data only available for epithelial ovarian masses
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Cuello 1999 (Continued)
Flow and timing FS before PS.
Comparative
Notes -
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Was the sample representative
of patients in practice (90%
stage I/II with RMI>200)?
Unclear
Low
DOMAIN 2: Index Test All tests
Were the index tests interpreted
without knowledge of the refer-
ence standard?
Yes
Were the index tests Interpreted
by consultant or specialist gyn-
onc pathologist?
Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
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Cuello 1999 (Continued)
Low
DOMAIN 4: Flow and Timing
Did all patients receive a refer-
ence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were un-interpretable/inter-
mediate test results reported?
Yes
Were withdrawals from the
study explained?
Yes
Fanfani 2007
Study characteristics
Patient sampling Design: Retrospective
Setting: Italy
Accrual dates: Sept 1999 - Nov 2004
No participants: 693
No assessed: 325 inc 14 deferred
Inclusion criteria: Consecutive patients with adnexal mass
Included previous histological diagnosis: unclear
Patient characteristics and set-
ting
Consecutive patients with adnexal mass. Italy.
Index tests FS from 1-2 most representative samples (number of slides not spec)
Target condition and reference
standard(s)
Malignant (primary or secondary) or borderline on PS.
Flow and timing FS before PS.
Comparative
Notes 14 deferred cases.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
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Fanfani 2007 (Continued)
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Was the sample representative
of patients in practice (90%
stage I/II with RMI>200)?
Unclear
Low
DOMAIN 2: Index Test All tests
Were the index tests interpreted
without knowledge of the refer-
ence standard?
Yes
Were the index tests Interpreted
by consultant or specialist gyn-
onc pathologist?
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Did all patients receive a refer-
ence standard?
Yes
Did all patients receive the same
reference standard?
Yes
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Fanfani 2007 (Continued)
Were un-interpretable/inter-
mediate test results reported?
Yes
Were withdrawals from the
study explained?
Yes
García 1997
Study characteristics
Patient sampling Design: Retrospective
Setting: Valencia
Accrual dates: Jan 1994 to Oct 1995
No participants: 30
No assessed: 30
Inclusion criteria: Women with adnexal mass undergoing FS. None other given.
Included previous histological diagnosis: unclear
Patient characteristics and set-
ting
Uncertain setting in Valencia
Index tests FS between 6-7 sections per specimen.
Target condition and reference
standard(s)
Malignant or borderline on PS.
Flow and timing FS before PS.
Comparative
Notes -
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Unclear
Did the study avoid inappropri-
ate exclusions?
Unclear
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García 1997 (Continued)
Was the sample representative
of patients in practice (90%
stage I/II with RMI>200)?
Unclear
Unclear
DOMAIN 2: Index Test All tests
Were the index tests interpreted
without knowledge of the refer-
ence standard?
Yes
Were the index tests Interpreted
by consultant or specialist gyn-
onc pathologist?
Unclear
Unclear
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Did all patients receive a refer-
ence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were un-interpretable/inter-
mediate test results reported?
No
Were withdrawals from the
study explained?
No
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Gorisek 2009
Study characteristics
Patient sampling Design: Retrospective
Setting: Slovenia
Accrual dates: 1 January 1993 - 31 December 2001
No participants: 131
No assessed: 131
Inclusion criteria: Women treated for benign, borderline and malignant ovarian tumours
Included previous histological diagnosis: unclear
Patient characteristics and set-
ting
Women treated for benign, borderline and malignant ovarian tumour. Slovenia
Index tests FS “After tumour removal, the fresh surgical specimen was immediately taken to the Department
of Pathologic Morphology at the Maribor Teaching Hospital (now the University Clinical Centre
Maribor). A pathologist prepared specimens from representative regions, froze them in a cryostat
and cut slices with a microtome. The slices were mounted on a glass slide, stained with haematoxylin
and eosin, and were then ready for microscopic evaluation.”
Target condition and reference
standard(s)
Malignant or borderline on PS.
Flow and timing FS before PS.
Comparative
Notes -
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Was the sample representative
of patients in practice (90%
stage I/II with RMI>200)?
Unclear
Unclear
58Intraoperative frozen section analysis for the diagnosis of early stage ovarian cancer in suspicious pelvic masses (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Gorisek 2009 (Continued)
DOMAIN 2: Index Test All tests
Were the index tests interpreted
without knowledge of the refer-
ence standard?
Yes
Were the index tests Interpreted
by consultant or specialist gyn-
onc pathologist?
Unclear
Unclear
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Did all patients receive a refer-
ence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were un-interpretable/inter-
mediate test results reported?
No
Were withdrawals from the
study explained?
Unclear
Hamed 1993
Study characteristics
Patient sampling Design: Retrospective
Setting: Chile
Accrual dates: Jan 1987-Oct 1992
No participants: 324
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Hamed 1993 (Continued)
No assessed: 324
Inclusion criteria: Women with peristent pelvic masses aged 9-81years
Included previous histological diagnosis: unclear
Patient characteristics and set-
ting
Women with peristent pelvic masses aged 9-81years. Chile.
Index tests FS. 5micron sections of tissue 3-4cmx2-3mm from mass
Target condition and reference
standard(s)
Malignant or borderline on PS.
Flow and timing FS before PS.
Comparative
Notes Large age group, not certain representtaive of suspicious masses
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Was the sample representative
of patients in practice (90%
stage I/II with RMI>200)?
No
High
DOMAIN 2: Index Test All tests
Were the index tests interpreted
without knowledge of the refer-
ence standard?
Yes
Were the index tests Interpreted
by consultant or specialist gyn-
onc pathologist?
Unclear
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Hamed 1993 (Continued)
Unclear
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear
DOMAIN 4: Flow and Timing
Did all patients receive a refer-
ence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were un-interpretable/inter-
mediate test results reported?
Yes
Were withdrawals from the
study explained?
Yes
Ilker 2011
Study characteristics
Patient sampling Design: Retrospective
Setting: Turkey
Accrual dates: Jan 2002 - Dec 2008
No participants: 278
No assessed: 266
Inclusion criteria: Patients undergoing surgery for ovarian mass where FS performed
Included previous histological diagnosis: unclear
Patient characteristics and set-
ting
Ovarian mass. Turkey.
Index tests FS 2-5 (5µm) slides from suspicious areas, reported by “expert” pathologist
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Ilker 2011 (Continued)
Target condition and reference
standard(s)
Malignant or borderline on PS.
Flow and timing FS before PS.
Comparative
Notes 12 deferred cases.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Was the sample representative
of patients in practice (90%
stage I/II with RMI>200)?
No
High
DOMAIN 2: Index Test All tests
Were the index tests interpreted
without knowledge of the refer-
ence standard?
Yes
Were the index tests Interpreted
by consultant or specialist gyn-
onc pathologist?
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
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Ilker 2011 (Continued)
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Did all patients receive a refer-
ence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were un-interpretable/inter-
mediate test results reported?
Yes
Were withdrawals from the
study explained?
Yes
Ilvan 2005
Study characteristics
Patient sampling Design: Retrospective
Setting: Turkey
Accrual dates: Jan 1995 to Dec 2003
No participants: 617
No assessed: 617
Inclusion criteria: Ovarianmasses sent for FS.No exclusions given. Included grossly benign tumours
(22 endometriotic, 3 follicles, 12 mature teratomas, 9 benign serous cytsadneomas).
Included previous histological diagnosis: unclear
Patient characteristics and set-
ting
Pelvic masses in women referred to a tertiary centre. Grossly benign specimens submitted in 46 cases
Index tests FS. Gross examination, touch imprints, sections (between 1 and 4) of ovary. 2 pathologisst in gyn
oncology
Target condition and reference
standard(s)
Malignant and borderline disease. PS. 2 pathologists experienced in gynaecological pathology in-
terpreted FS. Pathologists also employed touch imprint technique
Flow and timing Some FS diagnosis (7.5%) made on gross inspection only FS before PS
Comparative
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Ilvan 2005 (Continued)
Notes 46 grossly benign masses including 22 endometriotic cyst, 3 follicles, 12 mature teratomas, 9 benign
serous cystadenomas
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Was the sample representative
of patients in practice (90%
stage I/II with RMI>200)?
Unclear
High
DOMAIN 2: Index Test All tests
Were the index tests interpreted
without knowledge of the refer-
ence standard?
Yes
Were the index tests Interpreted
by consultant or specialist gyn-
onc pathologist?
Yes
High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
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DOMAIN 4: Flow and Timing
Did all patients receive a refer-
ence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were un-interpretable/inter-
mediate test results reported?
No
Were withdrawals from the
study explained?
Unclear
Kokka 2009
Study characteristics
Patient sampling Design: Retrospective
Setting: UK
Accrual dates: Oct 2006 - May 2008
No participants: 61
No assessed: 50
Inclusion criteria:-
Included previous histological diagnosis: unclear
Patient characteristics and set-
ting
Unclear inclusion criteria.
Index tests FS. No details given.
Target condition and reference
standard(s)
Malignant or borderline on PS.
Flow and timing FS before PS.
Comparative
Notes FS was considered in 71 patients; ten cases were excluded because of valid reasons; in 11 of 31
benign tumours FS was not requested by the surgeon
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
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DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Was the sample representative
of patients in practice (90%
stage I/II with RMI>200)?
Unclear
Low
DOMAIN 2: Index Test All tests
Were the index tests interpreted
without knowledge of the refer-
ence standard?
Yes
Were the index tests Interpreted
by consultant or specialist gyn-
onc pathologist?
Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Did all patients receive a refer-
ence standard?
Yes
Did all patients receive the same
reference standard?
Yes
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Kokka 2009 (Continued)
Were un-interpretable/inter-
mediate test results reported?
Yes
Were withdrawals from the
study explained?
Yes
Lim 1997
Study characteristics
Patient sampling Design: Retrospective
Setting: Singapore
Accrual dates: Jan 1988 to Dec 1994
No participants: 173
No assessed: 171
Inclusion criteria: Women with ovarian tumours and laparotomy and FS. No other inclusion details.
Included previous histological diagnosis: unclear
Patient characteristics and set-
ting
University hospital, Singapore. Pelvic masses. Uncertain if previous diagnosis cancer. Majority of
cases benign. Authors describe liberal use of frozen section in their hospital, even if mass thought
to be benign
Index tests FS. If discordant, pathologist reassessed if sampling or interpretational error
Target condition and reference
standard(s)
Malignant or borderline on PS
Flow and timing FS before PS. Ultrasound features correlated to final outcome
Comparative
Notes 2 cases FS diagnosis deferred and not included in analysis. Both were interpretational errors. When
accuracy of FS was reassessed for cases where FS was clinically indicated, accuracy was 95.5% (105
out of 110) for benign, borderline or malignant
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
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Lim 1997 (Continued)
Was a case-control design
avoided?
Unclear
Did the study avoid inappropri-
ate exclusions?
Unclear
Was the sample representative
of patients in practice (90%
stage I/II with RMI>200)?
No
High
DOMAIN 2: Index Test All tests
Were the index tests interpreted
without knowledge of the refer-
ence standard?
Yes
Were the index tests Interpreted
by consultant or specialist gyn-
onc pathologist?
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Did all patients receive a refer-
ence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were un-interpretable/inter-
mediate test results reported?
Yes
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Lim 1997 (Continued)
Were withdrawals from the
study explained?
Yes
Maheshwari 2006
Study characteristics
Patient sampling Design: Retrospective
Setting: India
Accrual dates: 1997-2001
No participants: 241
No assessed: 210
Inclusion criteria: Excluded non-ovarian FS and deferred FS.
Included previous histological diagnosis: unclear, included cases with previous cancer at another site
Patient characteristics and set-
ting
Unclear inclusion criteria. India.
Index tests FS. 1-4 sections at 7-8micrometer intervals.
Target condition and reference
standard(s)
Malignant or borderline on PS.
Flow and timing FS before PS.
Comparative
Notes Included ’clinically benign tumours with raised CA125’
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
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Maheshwari 2006 (Continued)
Was the sample representative
of patients in practice (90%
stage I/II with RMI>200)?
Unclear
Unclear
DOMAIN 2: Index Test All tests
Were the index tests interpreted
without knowledge of the refer-
ence standard?
Yes
Were the index tests Interpreted
by consultant or specialist gyn-
onc pathologist?
Unclear
Unclear
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Did all patients receive a refer-
ence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were un-interpretable/inter-
mediate test results reported?
Yes
Were withdrawals from the
study explained?
Yes
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Malipatil 2013
Study characteristics
Patient sampling Design: Retrospective
Setting: India
Accrual dates: 1999 - 2008
No participants: 223
No assessed: 218
Inclusion criteria: 5 exclusions - FS diagnosis deferred due to extensive necrosis / haemorrhage
Included previous histological diagnosis: unclear
Patient characteristics and set-
ting
Unclear inclusion criteria. India.
Index tests FS. At least 2 general surgical pathologists reporting FS. Mean number of FS 2 (1-5) and PS 7 (1-
33)
Target condition and reference
standard(s)
Malignant or borderline on PS.
Flow and timing FS before PS.
Comparative
Notes 377 referrals for diagnosis; intraoperative diagnosis sought in 233 (apparently 223?) cases; diagnosis
deferred in five cases due to extensive areas of haemorrhage and necrosis and was excluded from
further analysis; 218 cases analysed
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Was the sample representative
of patients in practice (90%
stage I/II with RMI>200)?
Unclear
Unclear
DOMAIN 2: Index Test All tests
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Were the index tests interpreted
without knowledge of the refer-
ence standard?
Yes
Were the index tests Interpreted
by consultant or specialist gyn-
onc pathologist?
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Did all patients receive a refer-
ence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were un-interpretable/inter-
mediate test results reported?
Yes
Were withdrawals from the
study explained?
Yes
Naik 2006
Study characteristics
Patient sampling Design: Retrospective
Setting: UK
Accrual dates: July 2002 to June 2003
No participants: 130
No assessed: 130 inc. 1 deferred
Inclusion criteria: Suspicious pelvic masses
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Naik 2006 (Continued)
Included previous histological diagnosis: yes
Patient characteristics and set-
ting
Suspicious pelvbic masses. Tertiary centre, UK.
Index tests FS. No details given.
Target condition and reference
standard(s)
Malignant or borderline on PS.
Flow and timing FS before PS.
Comparative
Notes 1 deferred was benign.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Was the sample representative
of patients in practice (90%
stage I/II with RMI>200)?
Yes
Low
DOMAIN 2: Index Test All tests
Were the index tests interpreted
without knowledge of the refer-
ence standard?
Yes
Were the index tests Interpreted
by consultant or specialist gyn-
onc pathologist?
Unclear
Low
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Naik 2006 (Continued)
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low
DOMAIN 4: Flow and Timing
Did all patients receive a refer-
ence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were un-interpretable/inter-
mediate test results reported?
Yes
Were withdrawals from the
study explained?
Yes
Pavlakis 2009
Study characteristics
Patient sampling Design: Retrospective
Setting: Greece
Accrual dates: Jan 2000 to Oct 2006
No participants: 932
No assessed: 932
Inclusion criteria: Ovarian or related masses submitted for FS. No other details given.
Included previous histological diagnosis: unclear
Patient characteristics and set-
ting
FS received from various centres. Uncertain if suspicious of malignancy when submitted. Ovarian
and related masses sent. 594 of 932 specimens benign on PS
Index tests FS. 1 to3 sections per ovarian or related mass. Examined by gynaecological pathologist
Target condition and reference
standard(s)
Malignant or borderline on PS.
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Flow and timing FS before PS.
Comparative
Notes Uncertain if only suspicious ovarian masses included. Risk of selection bias. Also, only epithelial
tumours reported in 3 x 3 table
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Unclear
Did the study avoid inappropri-
ate exclusions?
Unclear
Was the sample representative
of patients in practice (90%
stage I/II with RMI>200)?
Unclear
High
DOMAIN 2: Index Test All tests
Were the index tests interpreted
without knowledge of the refer-
ence standard?
Yes
Were the index tests Interpreted
by consultant or specialist gyn-
onc pathologist?
Yes
Unclear
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
Unclear
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of the results of the index tests?
Unclear
DOMAIN 4: Flow and Timing
Did all patients receive a refer-
ence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were un-interpretable/inter-
mediate test results reported?
No
Were withdrawals from the
study explained?
No
Pinto 2001
Study characteristics
Patient sampling Design: Retrospective
Setting: Brazil
Accrual dates: jan 1994 to April 1999
No participants: 243
No assessed: 243
Inclusion criteria: Ovarian tumours. No other details given.
Included previous histological diagnosis: unclear
Patient characteristics and set-
ting
Pathology laboratory in Brazil. Uncertain if tertiary referral centre for gynaecological malignancies
Index tests FS. 1 to 3 sections per specimen reporrted by general pathologist. All slides reviewed by specialist
gynaecological pathologist
Target condition and reference
standard(s)
Malignant or borderline on PS. Histological type noted.
Flow and timing FS before PS.
Comparative
Notes All slides (FS and PS) checked by a specialist gynaecological pathologist
Methodological quality
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Pinto 2001 (Continued)
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Unclear
Did the study avoid inappropri-
ate exclusions?
Unclear
Was the sample representative
of patients in practice (90%
stage I/II with RMI>200)?
Unclear
Unclear
DOMAIN 2: Index Test All tests
Were the index tests interpreted
without knowledge of the refer-
ence standard?
Yes
Were the index tests Interpreted
by consultant or specialist gyn-
onc pathologist?
Yes
Unclear
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Did all patients receive a refer-
ence standard?
Yes
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Pinto 2001 (Continued)
Did all patients receive the same
reference standard?
Yes
Were un-interpretable/inter-
mediate test results reported?
No
Were withdrawals from the
study explained?
No
Puls 1997
Study characteristics
Patient sampling Design: Retrospective
Setting: South Carolina
Accrual dates: 12 years
No participants: 294
No assessed: 294
Inclusion criteria: Included all women with both FS and PS analysis of ovarian tumour (serous or
mucinous).
Included previous histological diagnosis: nr
Patient characteristics and set-
ting
Ovarian tumour. Preoperative diagnosis unclear. South Carolina
Index tests FS. One section per centimetre of wall. In most cases, same pathologist repotrted FS and PS. Pool
of 8 pathologists reporting, expertise not given
Target condition and reference
standard(s)
Malignant and borderline serous and mucinous ovarian tumours on PS
Flow and timing Only PS which had conclusive FS were included FS before PS.
Comparative
Notes Of 632 operations, 294 were selected for having both FS and PS. Inconclusive FS is likely to have
been excluded
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
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Puls 1997 (Continued)
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Was the sample representative
of patients in practice (90%
stage I/II with RMI>200)?
Unclear
Low
DOMAIN 2: Index Test All tests
Were the index tests interpreted
without knowledge of the refer-
ence standard?
No
Were the index tests Interpreted
by consultant or specialist gyn-
onc pathologist?
Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
No
Low
DOMAIN 4: Flow and Timing
Did all patients receive a refer-
ence standard?
Yes
Did all patients receive the same
reference standard?
Yes
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Puls 1997 (Continued)
Were un-interpretable/inter-
mediate test results reported?
No
Were withdrawals from the
study explained?
Yes
Rakhshan 2009
Study characteristics
Patient sampling Design: Retrospective
Setting: Iran
Accrual dates: March 1994 - May 2008
No participants: 282
No assessed: 282
Inclusion criteria: Ovarian masses submitted for frozen section
Included previous histological diagnosis: unclear
Patient characteristics and set-
ting
Ovarian masses. Iran.
Index tests FS. 1-5 (5µm) sections interpreted by 1 of 5 attending general pathologists. All FS specimens
reviewed by specialist gynae pathologists for study
Target condition and reference
standard(s)
Malignant or borderline on PS.
Flow and timing FS before PS.
Comparative
Notes No deferred cases. Large proportion of cases benign.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
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Rakhshan 2009 (Continued)
Did the study avoid inappropri-
ate exclusions?
Unclear
Was the sample representative
of patients in practice (90%
stage I/II with RMI>200)?
Unclear
Unclear
DOMAIN 2: Index Test All tests
Were the index tests interpreted
without knowledge of the refer-
ence standard?
Yes
Were the index tests Interpreted
by consultant or specialist gyn-
onc pathologist?
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Did all patients receive a refer-
ence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were un-interpretable/inter-
mediate test results reported?
Yes
Were withdrawals from the
study explained?
Yes
81Intraoperative frozen section analysis for the diagnosis of early stage ovarian cancer in suspicious pelvic masses (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Rose 1994
Study characteristics
Patient sampling Design: Retrospective
Setting: USA
Accrual dates: June1983-1993
No participants: 383
No assessed: 383
Inclusion criteria: None given
Included previous histological diagnosis: unclear
Patient characteristics and set-
ting
Unclear inclusion criteria. USA.
Index tests FS. 0-4 sections at 2-3mm intervals
Target condition and reference
standard(s)
Malignant or borderline on PS.
Flow and timing FS before PS.
Comparative
Notes -
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Was the sample representative
of patients in practice (90%
stage I/II with RMI>200)?
Unclear
Unclear
DOMAIN 2: Index Test All tests
Were the index tests interpreted
without knowledge of the refer-
Yes
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ence standard?
Were the index tests Interpreted
by consultant or specialist gyn-
onc pathologist?
Unclear
Unclear
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Did all patients receive a refer-
ence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were un-interpretable/inter-
mediate test results reported?
No
Were withdrawals from the
study explained?
No
Stewart 2006
Study characteristics
Patient sampling Design: retrospective
Setting: tertiary hospital, Australia
Accrual dates: Jan 1999 to Dec 2003
No participants: 914
No assessed: 914
Inclusion criteria: FS of omentum and lymph node included.
Included previous histological diagnosis: NR
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Stewart 2006 (Continued)
Patient characteristics and set-
ting
Tertiary centre pelvic masses. FS of omentum and lymph node included
Index tests FS of omentum and lymph node included. Pathologhists in general surgery and gyn oncology
employed
Target condition and reference
standard(s)
Malignant or borderline on PS.
Flow and timing FS before PS.
Comparative
Notes Good study with useful 2 x 2 table
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Was the sample representative
of patients in practice (90%
stage I/II with RMI>200)?
Unclear
Low
DOMAIN 2: Index Test All tests
Were the index tests interpreted
without knowledge of the refer-
ence standard?
Yes
Were the index tests Interpreted
by consultant or specialist gyn-
onc pathologist?
Yes
Low
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DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Did all patients receive a refer-
ence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were un-interpretable/inter-
mediate test results reported?
No
Were withdrawals from the
study explained?
Yes
Subbian 2013
Study characteristics
Patient sampling Design: Retrospective
Setting: India
Accrual dates: March 2004 - January 2006
No participants: 135
No assessed: 117
Inclusion criteria: Retrospective analysis of reports of frozen section and paraffin block diagnoses of
patients undergoing surgery as primary line of therapy for suspected ovarian neoplasms
Included previous histological diagnosis: unclear
Patient characteristics and set-
ting
Suspected ovarian neoplasms, India.
Index tests FS. “All the frozen section diagnoses were made by a team of expert onco pathologists at the
institute. Before sectioning, gross examination of the tumor was carried out and frozen section
samples were taken from solid or suspicious areas. The number of bits sampled varied from one to
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Subbian 2013 (Continued)
three (average of two). The frozen section and the permanent section reports of each patient were
compared. The frozen section results were divided into the following groups: Deferred, benign,
borderline and malignant. Reports mentioned as ‘suggestive of ’, ‘suspicious of ’ or ‘compatible with’
were included in the diagnoses mentioned.”
Target condition and reference
standard(s)
Malignant or borderline on PS.
Flow and timing FS before PS.
Comparative
Notes Retrospective selection based on having had FS and PS . Deferred cases: 8/135 (5.9%). Ten patients
diagnosed with non neoplastic conditions were also excluded
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Was the sample representative
of patients in practice (90%
stage I/II with RMI>200)?
Unclear
Low
DOMAIN 2: Index Test All tests
Were the index tests interpreted
without knowledge of the refer-
ence standard?
Yes
Were the index tests Interpreted
by consultant or specialist gyn-
onc pathologist?
Yes
Low
DOMAIN 3: Reference Standard
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Subbian 2013 (Continued)
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Did all patients receive a refer-
ence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were un-interpretable/inter-
mediate test results reported?
No
Were withdrawals from the
study explained?
Yes
Sukumaran 2014
Study characteristics
Patient sampling Design: Retrospective
Setting: India
Accrual dates: 2009-2012
No participants: 237
No assessed: 233 (4 deferred)
Inclusion criteria: Excluded torsion
Included previous histological diagnosis: unclear
Patient characteristics and set-
ting
Torted pelvoic masses excluded. India.
Index tests FS. 2-5 sections each 4-5microns
Target condition and reference
standard(s)
Malignant or borderline on PS.
Flow and timing FS before PS.
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Comparative
Notes 4 deferred on FS.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Was the sample representative
of patients in practice (90%
stage I/II with RMI>200)?
Unclear
Low
DOMAIN 2: Index Test All tests
Were the index tests interpreted
without knowledge of the refer-
ence standard?
Yes
Were the index tests Interpreted
by consultant or specialist gyn-
onc pathologist?
Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
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DOMAIN 4: Flow and Timing
Did all patients receive a refer-
ence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were un-interpretable/inter-
mediate test results reported?
Yes
Were withdrawals from the
study explained?
Yes
Suprasert 2008
Study characteristics
Patient sampling Design: Retrospective review
Setting: Thailand
Accrual dates: Jan 2001 to Dec 2005
No participants: 127
No assessed: 112
Inclusion criteria: Women with pelvic masses. Excluded infarcted masses (4) or deferred (18) frozen
section analysis.
Included previous histological diagnosis: no
Patient characteristics and set-
ting
Pelvic masses. Thailand.
Index tests FS. Number of frozen sections determined by attending Pathologist. Deferred FS when suspicion
of borderline or malignant considered not definitely diagnostic
Target condition and reference
standard(s)
Malignant or borderline on PS.
Flow and timing Specimens submitted to FS at surgeon’s discretion - no clear protocol. FS before PS
Comparative
Notes Retrospective review. 15 excluded due to infarction and deferred FS No stage given.Variable sections
were performed by Pathologist
Methodological quality
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Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
No
Was the sample representative
of patients in practice (90%
stage I/II with RMI>200)?
Unclear
Unclear
DOMAIN 2: Index Test All tests
Were the index tests interpreted
without knowledge of the refer-
ence standard?
Yes
Were the index tests Interpreted
by consultant or specialist gyn-
onc pathologist?
Unclear
Unclear
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Did all patients receive a refer-
ence standard?
Yes
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Did all patients receive the same
reference standard?
Yes
Were un-interpretable/inter-
mediate test results reported?
Yes
Were withdrawals from the
study explained?
Yes
Tangjitgamol 2004
Study characteristics
Patient sampling Design: Retrospective
Setting: Thailand
Accrual dates: Jan 1992 to Jan 2002
No participants: 212
No assessed: 212 inc. 13 deferred
Inclusion criteria: Intact ovarian masses submitted.
Included previous histological diagnosis: unclear
Patient characteristics and set-
ting
Intact ovarioan masses. Thailand.
Index tests FS. No details given.
Target condition and reference
standard(s)
Malignant or borderline on PS.
Flow and timing FS before PS.
Comparative
Notes Included 13 deferred (7 benign, 76 borderline, 121 malignant). High percentage malignant PS.
Risk selection bias
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
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Tangjitgamol 2004 (Continued)
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Was the sample representative
of patients in practice (90%
stage I/II with RMI>200)?
Unclear
Unclear
DOMAIN 2: Index Test All tests
Were the index tests interpreted
without knowledge of the refer-
ence standard?
Yes
Were the index tests Interpreted
by consultant or specialist gyn-
onc pathologist?
Unclear
Unclear
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Did all patients receive a refer-
ence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were un-interpretable/inter-
mediate test results reported?
Yes
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Tangjitgamol 2004 (Continued)
Were withdrawals from the
study explained?
Yes
Taskiran 2008
Study characteristics
Patient sampling Design: Retrospective
Setting: Turkey
Accrual dates: 1997 - 2006
No participants: 207
No assessed: 207 inc 3 deferred
Inclusion criteria: Consecutive exploratory laparotomies for pelvic mass
Included previous histological diagnosis: unclear
Patient characteristics and set-
ting
Pelvic masses. Turkey.
Index tests FS (5µm) from most suspected areas of mass, solid / papillary areas of tumour wall. No info on
number of slides or reporting pathologists
Target condition and reference
standard(s)
Malignant or borderline on PS.
Flow and timing FS beforer PS.
Comparative
Notes 3 deferred cases.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
93Intraoperative frozen section analysis for the diagnosis of early stage ovarian cancer in suspicious pelvic masses (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Taskiran 2008 (Continued)
Was the sample representative
of patients in practice (90%
stage I/II with RMI>200)?
Unclear
Low
DOMAIN 2: Index Test All tests
Were the index tests interpreted
without knowledge of the refer-
ence standard?
Yes
Were the index tests Interpreted
by consultant or specialist gyn-
onc pathologist?
Unclear
Unclear
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Did all patients receive a refer-
ence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were un-interpretable/inter-
mediate test results reported?
Yes
Were withdrawals from the
study explained?
Yes
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Toneva 2012
Study characteristics
Patient sampling Design: Retrospective
Setting: UK
Accrual dates: Oct 2005 - Sept 2008
No participants: 67
No assessed: 66
Inclusion criteria: FS in 67 cases (29.7%), 1 excluded due to missing data
Included previous histological diagnosis: unclear
Patient characteristics and set-
ting
Unclear inclusion criteria. UK.
Index tests FS. 3-5 sections.
Target condition and reference
standard(s)
Malignant or borderline on PS.
Flow and timing FS befiore PS.
Comparative
Notes -
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Was the sample representative
of patients in practice (90%
stage I/II with RMI>200)?
Yes
Low
DOMAIN 2: Index Test All tests
Were the index tests interpreted
without knowledge of the refer-
ence standard?
Yes
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Toneva 2012 (Continued)
Were the index tests Interpreted
by consultant or specialist gyn-
onc pathologist?
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Did all patients receive a refer-
ence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were un-interpretable/inter-
mediate test results reported?
Yes
Were withdrawals from the
study explained?
Yes
Torres 1998
Study characteristics
Patient sampling Design: Retrospective
Setting: Colombia
Accrual dates: Jan1994-Dec 1997
No participants: 199
No assessed: 199- (73 excluded, 3 deferred diagnoses)=123
Inclusion criteria: Mass
Included previous histological diagnosis: unclear
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Torres 1998 (Continued)
Patient characteristics and set-
ting
Pelvic masses. Columbia.
Index tests FS. No details given.
Target condition and reference
standard(s)
Malignnat on PS.
Flow and timing FS before PS.
Comparative
Notes -
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Unclear
Did the study avoid inappropri-
ate exclusions?
Unclear
Was the sample representative
of patients in practice (90%
stage I/II with RMI>200)?
Unclear
Unclear
DOMAIN 2: Index Test All tests
Were the index tests interpreted
without knowledge of the refer-
ence standard?
Yes
Were the index tests Interpreted
by consultant or specialist gyn-
onc pathologist?
Unclear
Unclear
DOMAIN 3: Reference Standard
97Intraoperative frozen section analysis for the diagnosis of early stage ovarian cancer in suspicious pelvic masses (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
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Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Did all patients receive a refer-
ence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were un-interpretable/inter-
mediate test results reported?
Yes
Were withdrawals from the
study explained?
Yes
Twaalfhoven 1991
Study characteristics
Patient sampling Design: Retrospective
Setting: Netherlands
Accrual dates: Jan 1984-Jan 1990
No participants: 176
No assessed: 176 inc. 11 deferred
Inclusion criteria: Included 27 ovarian biopsies and 149 ovaries.
Included previous histological diagnosis: unclear
Patient characteristics and set-
ting
Ovarian biopsies and ovaries submitted for FS. Netherlands.
Index tests FS. No details given.
Target condition and reference
standard(s)
Malignant or borderline on PS.
Flow and timing FS before PS.
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Comparative
Notes 11 Deferred (1 benign, 4 borderline, 6 malignant).
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Was the sample representative
of patients in practice (90%
stage I/II with RMI>200)?
Unclear
Unclear
DOMAIN 2: Index Test All tests
Were the index tests interpreted
without knowledge of the refer-
ence standard?
Yes
Were the index tests Interpreted
by consultant or specialist gyn-
onc pathologist?
Unclear
Unclear
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
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Twaalfhoven 1991 (Continued)
DOMAIN 4: Flow and Timing
Did all patients receive a refer-
ence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were un-interpretable/inter-
mediate test results reported?
Yes
Were withdrawals from the
study explained?
Unclear
Wakahara 2001
Study characteristics
Patient sampling Design: Prospective
Setting: Japan
Accrual dates: 1994 - 1999
No participants: 292
No assessed: 187
Inclusion criteria: None given
Included previous histological diagnosis: unclear
Patient characteristics and set-
ting
Unclear inclusion criteria. Japan.
Index tests FS. Single pathologist reported all FS and PS
Target condition and reference
standard(s)
Malignant or borderline on PS.
Flow and timing FS before PS.
Comparative
Notes Principal aim to assess performance of US / tumour markers in differentiating malignant from
benign adnexal masses
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
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Wakahara 2001 (Continued)
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Was the sample representative
of patients in practice (90%
stage I/II with RMI>200)?
Unclear
Unclear
DOMAIN 2: Index Test All tests
Were the index tests interpreted
without knowledge of the refer-
ence standard?
Yes
Were the index tests Interpreted
by consultant or specialist gyn-
onc pathologist?
Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Did all patients receive a refer-
ence standard?
Yes
Did all patients receive the same
reference standard?
Yes
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Wakahara 2001 (Continued)
Were un-interpretable/inter-
mediate test results reported?
No
Were withdrawals from the
study explained?
Unclear
Wang 1998
Study characteristics
Patient sampling Design: Retrospective
Setting: Taiwan
Accrual dates: Jan 1991 to June 1996
No participants: 299
No assessed: 299
Inclusion criteria: Unclear if all were pelvic masses. Also reported FS in lymphatic, uterine and other
tissue samples.
Included previous histological diagnosis: nr
Patient characteristics and set-
ting
Unclear if hospital setting. Pelvic masses. Taiwan.
Index tests FS. Berween 1 and several FS were performed each case. Different grades of pathologist were
employed. Most were general surgical pathologists (not gynaecological oncology pathologists.)
Target condition and reference
standard(s)
Benign, borderline and malignant ovarian diagnosis on PS.
Flow and timing FS before PS. Interpretation of ovaries varied in number of sections submitted for FS. Same pathol-
ogist reported both the FS and PS in most cases. Interpretation bias
Comparative
Notes Also reported FS in lymphatic, uterine and other tissue samples
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
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Wang 1998 (Continued)
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Was the sample representative
of patients in practice (90%
stage I/II with RMI>200)?
Unclear
High
DOMAIN 2: Index Test All tests
Were the index tests interpreted
without knowledge of the refer-
ence standard?
No
Were the index tests Interpreted
by consultant or specialist gyn-
onc pathologist?
No
High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
No
Low
DOMAIN 4: Flow and Timing
Did all patients receive a refer-
ence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were un-interpretable/inter-
mediate test results reported?
Yes
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Wang 1998 (Continued)
Were withdrawals from the
study explained?
Yes
Wasinghon 2008
Study characteristics
Patient sampling Design: Retrospective
Setting: Thailand
Accrual dates: Jan 2002 - Dec 2006
No participants: 376
No assessed: 376
Inclusion criteria: Consecutive ovarian tumours undergoing surgery where FS and PS performed
Included previous histological diagnosis: unclear
Patient characteristics and set-
ting
Consecutive ovarian masses. Thailand.
Index tests FS 1-2 slides, reported by 5 pathologists (expertise unclear)
Target condition and reference
standard(s)
Malignant or borderline on PS.
Flow and timing FS before PS.
Comparative
Notes No deferred cases.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
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Wasinghon 2008 (Continued)
Was the sample representative
of patients in practice (90%
stage I/II with RMI>200)?
Unclear
Low
DOMAIN 2: Index Test All tests
Were the index tests interpreted
without knowledge of the refer-
ence standard?
Yes
Were the index tests Interpreted
by consultant or specialist gyn-
onc pathologist?
Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Did all patients receive a refer-
ence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were un-interpretable/inter-
mediate test results reported?
Yes
Were withdrawals from the
study explained?
Yes
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Wootipoom 2006
Study characteristics
Patient sampling Design: Retrospective
Setting: Thailand
Accrual dates: May 1999 to Oct 2004
No participants: 229
No assessed: 213
Inclusion criteria: Excluded 16 deferred diagnoses.
Included previous histological diagnosis: unclear
Patient characteristics and set-
ting
Unclear inclusion criteria. Thailand.
Index tests FS. No details given.
Target condition and reference
standard(s)
Malignant or borderline on PS.
Flow and timing FS before PS.
Comparative
Notes 16 deferred diagnoses on FS excluded.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Was the sample representative
of patients in practice (90%
stage I/II with RMI>200)?
Unclear
Unclear
DOMAIN 2: Index Test All tests
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Wootipoom 2006 (Continued)
Were the index tests interpreted
without knowledge of the refer-
ence standard?
Yes
Were the index tests Interpreted
by consultant or specialist gyn-
onc pathologist?
Unclear
Unclear
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Did all patients receive a refer-
ence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were un-interpretable/inter-
mediate test results reported?
No
Were withdrawals from the
study explained?
Yes
Yarandi 2008
Study characteristics
Patient sampling Design: Retrospective
Setting: Iran
Accrual dates: Jan 2004 - Aug 2006
No participants: 106
No assessed: 106
Inclusion criteria: All women with ovarian tumours who had a FS diagnosis. Excluded patients with
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Yarandi 2008 (Continued)
neo-adjuvant chemo/radiotherapy.
Included previous histological diagnosis: unclear
Patient characteristics and set-
ting
Ovatian masses. Iran.
Index tests 2 - 5 samples for FS, samples for PS taken ’from 1cm over maximum tumour diameter’. Single
gynae-pathologist reported all FS and PS
Target condition and reference
standard(s)
Malignant or borderline on PS.
Flow and timing FS before PS.
Comparative
Notes -
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Was the sample representative
of patients in practice (90%
stage I/II with RMI>200)?
Unclear
Low
DOMAIN 2: Index Test All tests
Were the index tests interpreted
without knowledge of the refer-
ence standard?
Yes
Were the index tests Interpreted
by consultant or specialist gyn-
onc pathologist?
Yes
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Yarandi 2008 (Continued)
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Did all patients receive a refer-
ence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were un-interpretable/inter-
mediate test results reported?
No
Were withdrawals from the
study explained?
Yes
Yeo 1998
Study characteristics
Patient sampling Design: Retrospective
Setting: China
Accrual dates: Jan 1990 to Dec 1995
No participants: 316
No assessed: 316
Inclusion criteria: Pelvic masses.
Included previous histological diagnosis: unclear
Patient characteristics and set-
ting
Pelvic masses. Hospital, unknown if tertiary. China.
Index tests FS. 2 sections taken at FS in 85% cases. Experienced pathologist. Same pathologist reported PS and
FS
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Yeo 1998 (Continued)
Target condition and reference
standard(s)
Malignant or borderline on PS. PS performed by pathologist who interpreted FS. Third party quality
assurance performed by a third author
Flow and timing FS before PS.
Comparative
Notes -
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Was the sample representative
of patients in practice (90%
stage I/II with RMI>200)?
Unclear
Unclear
DOMAIN 2: Index Test All tests
Were the index tests interpreted
without knowledge of the refer-
ence standard?
Yes
Were the index tests Interpreted
by consultant or specialist gyn-
onc pathologist?
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
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Yeo 1998 (Continued)
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
No
Low
DOMAIN 4: Flow and Timing
Did all patients receive a refer-
ence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were un-interpretable/inter-
mediate test results reported?
No
Were withdrawals from the
study explained?
No
FS: frozen section; PS: paraffin section.
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Abbasi 2010 Conference abstract. Retrospective study of 105 patients comparing value of intraoperative cytology and
FS. Unable to construct 3 x 3 table from data
Abdel-Hady 2012 Not a DTA study. A study of fertility-conserving surgery for ovarian tumours in children and young adults
6-20 years of age. Although frozen section was performed, evaluation of its accuracy was not part of the
study
Abe 2013 Retrospective review of accuracy of FS and imprint cytology in 23 ovarian germ cell tumours
Ahmad 2008 Retrospective study of all FS analyses performed at an institution in Pakistan during 2006 (N = 356).
Cohort was not limited to women with ovarian tumours, who comprised only 9% of the sample
Alvarez Santin 2011 Retrospective study of intraoperative consultations of ovarian neoplastic and non-neoplastic lesions (N
= 337). Intraoperative diagnoses based on macroscopic exam, FS, imprint cytology or smears, and cyto-
histological correlation. Intraoperative diagnoses compared with final histologic diagnoses
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(Continued)
Anastasiadis 2002 Retrospective study of PW and imprint cytology for 52 patients undergoing primary surgery for ovarian
cancer
Aslam 2010 Retrospective study of FS analyses compared to preoperative ultrasound and final paraffin section diagnosis.
Investigators selected the first 400 women with malignant ovarian tumours and 400 with benign tumours
between August 2000 and March 2007. Cohort was not limited to early ovarian cancer and comprised a
significant proportion of metastatic tumours (56%). Sensitivity, specificity, PPV and NPV calculated but
unable to construct 3 x 3 table
Atallah 2004 Commentary on management of ovarian masses at laparoscopy, including role of FS. No comparison of
FS to PS
Basaran 2014 Only borderline cases
Bensaid 2006 Retrospective study of 313 patients to assess performance of laparoscopy +/- FS to identify malignancy. FS
performed in 111 (35%) patients. Results compared to final histology
Brun 2008 Retrospective study of patients with epithelial ovarian cancer only
Canis 1997 Laparoscopic versus laparotomy for management of pelvic masses
Chapron 1998 Review of laparoscopic management of pelvic masses. FS reserved for 26 pelvic masses with CA125 within
range of 4-76. Not representative of population being studied
Cheung 1992 Retrospective review of all ovarian masses sent for FS, including those to determine extent of metastases
and bilaterality of tumour; unable to construct 3 x 3 table from data for FS sent for suspicious pelvic masses
Cingillioglu 2011 Conference abstract. Retrospective study of borderline tumours diagnosed at FS, PS or both in a single
unit in Turkey 2000-2011
Coffey 2005 Review of role of intraoperative consultation, no data provided
Da Cunha Bastos 1983 Included obviously malignant masses. Expertise of pathologists unclear. Unable to extract data for 3 x 3
table
Dede 2005 Use of frozen section laparoscopically for predicted benign masses
Dottino 1999 Prospective study of 160 women undergoing laparoscopic evaluation with FS for adnexal masses. Large
masses above umbilicus excluded. No comparison with PS, only discordant cases reported
Fain-Kahn 2009 Ovarian cryoperservation amongst young women undergoing surgery for borderline ovarian tumours
Freitag 2004 Retrospective review of management of 38 patients with borderline ovarian tumours. Not comparing FS
to PS
Ganesan 2013 Survey of UK practice of FS in gynaecological oncology
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Garg 2011 Conference abstract. Retrospective study of 166 patients with borderline ovarian tumours only. FS and PS
results compared. Unable to construct 3 x 3 table from data
Geomini 2005 Meta-analysis
Geomini 2009 Survey on women’s attitudes towards frozen section diagnosis
Ghaemmaghami 2008 Retrospective study of 150 women undergoing laparotomy for adnexal masses in Iran. 143 had FS. Unable
to construct 3 x 3 table from data
Gocku 2013 Conference abstract only. Retrospective review of 113 tumours diagnosed on either PS or FS
Gol 2003 All of the data adds up to 221 women, but authors report 222 women. Table 2 data does not add up and
does not match data in text
Gultekin 2011 Retrospective study of 82 patients with borderline tumours only. FS and PS results compared
Gupta 2013 Conference abstract. Retrospective study of 52 patients with borderline tumours only. FS and PS results
compared, unable to construct 3 x 3 table
Guzel 2011 Prospective study of postmenopausal and women of reproductive age (N = 80) with predicted benign
adnexal masses. FS in 75% of cases but no data on accuracy
Guzin 2013 Conference abstract. Retrospective review of 40 borderline tumours diagnosed on either FS or PS
Harmon 2011 Conference abstract. Retrospective study of 100 consecutive ovarian mucinous tumours that underwent
FS. FS and PS results compared
Hua 2005 Full article in Chinese
Ismiil 2009 Retropsective review 731 FS from all gynaecological operations performed, 29 performed for ovarian cyst
and 591 from ovary/tube. 257 of these were performed by general gynaecologist or surgeon. This is not
representative of the population being studied
Ivanov 2005 Full article in Bulgarian
Jaafar 2005 Review of frozen section concepts. Not original research
Kato 2011 Review of histopathological features of FS for 40 clear cell carcinomas and 30 serous ovarian tumours
Kay kç o lu 2000 Retrospective study of 33 patients with borderline tumours only. FS and PS results compared
Khunamornpong 2003 Prospective study of 131 ovarian masses submitted for scrape cytology and not intraoperative frozen section
analysis
Kim 2009a Retrospective study of 101 patients with borderline tumours only. FS and PS results compared
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Kim 2009b Retrospective study of 209 patients with borderline tumours only. FS (182 cases) and PS results compared
Kim 2013 Conference abstract only. Retrospective review of 179 borderline tumours diagnosed on FS
Konopacka 2012 Prospective observational study of 131 patients undergoing laparoscopic surgery for adnexal masses. FS
performed in 87 cases. Unable to construct 3 x 3 table from data
Kumpulainen 2007 Prospective study of 65 patients with borderline tumours only to assess staging/treatment and outcomes
in different hospital settings. FS in half of cases, results compared to PS
Kushima 2013 3 case reports on usefulness of intraoperative cytology
Leng 2006 Retrospective review of benign pelvic masses managed with laparoscopy
Li 2009 Full article in Chinese
Lin 1993 Retrospective review of 80 women undergoing laparotomy for pelvic mass. FS in 48 cases with discussion
of discordant cases but no data provided
Liu 2010 Prospective review of diagnostic accuracy of haptoglobin level in ovarian cyst fluid for intraoperative triage
of epithelial ovarian cancers
Marana 2005 Prospective study of FS of adnexal masses at laparoscopy for ultrasonographically non-suspicious adnexal
mass
Maruoka 2003 Full article in Japanese
Medeiros 2005 Quantitative systematic review of diagnostic accuracy of FS, including 14 studies
Mendilcioglu 2002 Retrospective study of 61 patients undergoing laparoscopy for adnexal masses, aiming to assess the safety
of laparoscopic approach. FS performed in only 8 (13%) of cases
Menzin 1995 Retrospective review of 48 patients with FS diagnosis borderline tumour. 2 patients were stage II, 10
patients were stage III. This is not representative of the population being studied
Michael 1996 Comparison of cytology and frozen section. No comparison to paraffin section
Moodley 2005 Commentary on frozen section. Not original research
Morotti 2011 Conference abstract. Retrospective review of 98 borderline tumours diagnosed by FS, PS or both. Unable
to construct 3 x 3 table from data
Nasfi 2012 Retrospective study of 79 ovarian mucinous tumours that underwent FS. FS and PS results compared
Nevin 2010 Letter in response to Warwick 2009.
Obiakor 1991 Retrospective review of 311 FS classified as benign or malignant. Unable to construct 3 x 3 table from data
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(Continued)
Ozdamar 2006 Retrospective review of all FS analysed in a pathology laboratory 2001-2005. No details provided for
ovarian masses alone
Parker 2011 Conference abstract only. Review of 831 frozen sections interpreted by general or specialist gynaecological
pathologists
Pongsuvareeyakul 2012 Retrospective study of mucinous tumours only
Puga 2011 Conference abstract. Retrospective study of 67 patients with borderline tumours only. Unable to construct
3 x 3 table from data
Quan 2004 31 patients with stage IV breast cancer with either adnexal mass or undergoing therapeutic BSO. Not
representative of population being studied in this review
Saglam 2006 Letter to editor discussing 4 discordant cases of a total 174 FS performed during 2002 in a single unit
Sakurai 2004 Full article in Japanese
Salman 2013 Conference abstract only. 745 pelvic masses undergoing FS
Scurry 1989 Retrospective review of 203 FS from all gynaecological operations, including 73 ovarian. No report that
these were suspicious masses. Authors agree that many FS were performed on grossly benign appearing
cysts. Not representative of population being studied in this review
Seckin 2011 Retrospective study of females 25 years or younger undergoing laparoscopic surgery for presumed benign
ovarian cysts
Shahid 2012 Reports role of intraoperative cytology not frozen section.
Shih 2011 Retrospective study of 120 patients with borderline tumours diagnosed at FS
Slavutin 1979 Retrospective study of 55 patients with serous ovarian tumours. FS and PS reviewed by 2 pathologists for
study and compared with original results
Song 2011 Retrospective study of 354 patients with borderline tumours only. FS and PS results compared
Souka 1990 Retrospective review of combined use of imprint cytology and FS to evaluate 50 pelvicmasses at laparotomy.
Borderline tumours at PS were grouped together with malignant. Unable to construct 3 x 3 table
Spann 1994 Report on role of FS and gross inspection combined. Unable to extract data for FS alone. May not be
representative of study population as 88% of intraoperative consultations were benign diagnoses
Springel 2009 Retrospective study of FS intraoperative consultations reported as epithelial ovarian tumours
Stewart 2005 Retrospective study of 914 patients in Australia looking at accuracy of FS to determine primary from
metastatic disease, 1999-2003. 32 patients known to have extra-ovarian disease at time of FS. Patient
selection bias therefore high. FS omentum and lymph node included
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Stewart 2008 Results for clear cell carcinoma were assessed separately and compared with a similar number with serous
and endometrial cancer
Stewart 2010 402 cases where cytology was compared to frozen section. No comparison to paraffin section made
Storms 2012 Retrospective review of 73 ovarian mucinous tumours
Takemoto 2014 Retrospective review of benign masses diagnosed at FS at laparoscopy. Not representative of study popu-
lation
Tempfer 2007 Borderline tumours only
Twigg 2012 Letter in response to Cross 2012
Uguz 2005 Prospective study of 62 women having FNAC of ovarian masses and not intraoperative frozen section
analysis
Ulrich 2000 Retrospective analysis of FS results for 226 adnexal masses. Excluded simple masses on USS and suspicious
masses that required conversion to laparotomy. Heavy selection bias in that masses not considered to need
laparotomy were excluded. As a result, 202 of 211 studied women had benign disease on PS
Usubutun 1998 Retrospective review of 360 ovarian masses with FS. 12 deferred cases. Unable to construct 3 x 3 table
from data
Vemavarapu 2014 Conference abstract only. Retrospective review of 73 pelvic masses submitted for FS
Vijayakumar 2013 Prospective study of intraoperative imprint cytology in 50 patients with suspected ovarian malignancy
Warwick 2009 Retrospective study to determine optimal management strategy for women with suspected stage I ovarian
cancer. No data on FS accuracy
Wingo 2006 Retrospective study of 32 patients with borderline (low malignant potential) tumours only
Zhang 1993 Full article in Chinese
FNAC: fine needle aspiration cytology; FS: frozen section; NPV: negative predictive value; PPV: positive predictive value; PS: paraffin
section; PW: peritoneal washing; USS: ultrasound scan.
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D A T A
Presented below are all the data for all of the tests entered into the review.
Tests. Data tables by test
Test
No. of
studies
No. of
participants
1 Frozen section: Threshold
Malignancy vs Borderline or
Benign
38 11181
2 Frozen section: Threshold
Malignancy or Borderline vs
Benign
38 11181
3 Frozen section: Threshold
Malignancy vs Borderline or
Benign when FS indicated Mal
or BOT
38 3953
Test 1. Frozen section: Threshold Malignancy vs Borderline or Benign.
Review: Intraoperative frozen section analysis for the diagnosis of early stage ovarian cancer in suspicious pelvic masses
Test: 1 Frozen section: Threshold Malignancy vs Borderline or Benign
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
A ikalin 2014 132 0 6 144 0.96 [ 0.91, 0.98 ] 1.00 [ 0.97, 1.00 ]
Bazot 2006 29 1 7 114 0.81 [ 0.64, 0.92 ] 0.99 [ 0.95, 1.00 ]
Bige 2011 115 5 6 393 0.95 [ 0.90, 0.98 ] 0.99 [ 0.97, 1.00 ]
Boriboonhirunsarn 2004 47 0 5 95 0.90 [ 0.79, 0.97 ] 1.00 [ 0.96, 1.00 ]
Canis 2004 18 3 4 111 0.82 [ 0.60, 0.95 ] 0.97 [ 0.93, 0.99 ]
Cross 2012 415 5 101 918 0.80 [ 0.77, 0.84 ] 0.99 [ 0.99, 1.00 ]
Cuello 1999 67 3 4 415 0.94 [ 0.86, 0.98 ] 0.99 [ 0.98, 1.00 ]
Fanfani 2007 106 2 21 182 0.83 [ 0.76, 0.89 ] 0.99 [ 0.96, 1.00 ]
Garc a 1997 7 0 4 19 0.64 [ 0.31, 0.89 ] 1.00 [ 0.82, 1.00 ]
Gorisek 2009 73 0 9 49 0.89 [ 0.80, 0.95 ] 1.00 [ 0.93, 1.00 ]
Hamed 1993 55 1 0 268 1.00 [ 0.94, 1.00 ] 1.00 [ 0.98, 1.00 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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(. . . Continued)
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Ilker 2011 20 0 8 238 0.71 [ 0.51, 0.87 ] 1.00 [ 0.98, 1.00 ]
Ilvan 2005 104 0 16 384 0.87 [ 0.79, 0.92 ] 1.00 [ 0.99, 1.00 ]
Kokka 2009 19 0 1 30 0.95 [ 0.75, 1.00 ] 1.00 [ 0.88, 1.00 ]
Lim 1997 34 0 1 136 0.97 [ 0.85, 1.00 ] 1.00 [ 0.97, 1.00 ]
Maheshwari 2006 86 2 6 116 0.93 [ 0.86, 0.98 ] 0.98 [ 0.94, 1.00 ]
Malipatil 2013 45 0 8 165 0.85 [ 0.72, 0.93 ] 1.00 [ 0.98, 1.00 ]
Naik 2006 40 1 5 83 0.89 [ 0.76, 0.96 ] 0.99 [ 0.94, 1.00 ]
Pavlakis 2009 135 0 19 691 0.88 [ 0.81, 0.92 ] 1.00 [ 0.99, 1.00 ]
Pinto 2001 64 1 5 173 0.93 [ 0.84, 0.98 ] 0.99 [ 0.97, 1.00 ]
Puls 1997 27 1 11 255 0.71 [ 0.54, 0.85 ] 1.00 [ 0.98, 1.00 ]
Rakhshan 2009 60 1 5 216 0.92 [ 0.83, 0.97 ] 1.00 [ 0.97, 1.00 ]
Rose 1994 111 1 9 262 0.93 [ 0.86, 0.97 ] 1.00 [ 0.98, 1.00 ]
Stewart 2006 251 4 15 644 0.94 [ 0.91, 0.97 ] 0.99 [ 0.98, 1.00 ]
Subbian 2013 55 1 5 56 0.92 [ 0.82, 0.97 ] 0.98 [ 0.91, 1.00 ]
Sukumaran 2014 73 1 15 144 0.83 [ 0.73, 0.90 ] 0.99 [ 0.96, 1.00 ]
Suprasert 2008 46 0 4 62 0.92 [ 0.81, 0.98 ] 1.00 [ 0.94, 1.00 ]
Tangjitgamol 2004 62 0 10 127 0.86 [ 0.76, 0.93 ] 1.00 [ 0.97, 1.00 ]
Taskiran 2008 90 0 2 112 0.98 [ 0.92, 1.00 ] 1.00 [ 0.97, 1.00 ]
Toneva 2012 25 0 3 38 0.89 [ 0.72, 0.98 ] 1.00 [ 0.91, 1.00 ]
Torres 1998 28 2 7 86 0.80 [ 0.63, 0.92 ] 0.98 [ 0.92, 1.00 ]
Twaalfhoven 1991 54 0 6 105 0.90 [ 0.79, 0.96 ] 1.00 [ 0.97, 1.00 ]
Wakahara 2001 54 0 0 133 1.00 [ 0.93, 1.00 ] 1.00 [ 0.97, 1.00 ]
Wang 1998 69 0 4 223 0.95 [ 0.87, 0.98 ] 1.00 [ 0.98, 1.00 ]
Wasinghon 2008 82 8 21 265 0.80 [ 0.71, 0.87 ] 0.97 [ 0.94, 0.99 ]
Wootipoom 2006 68 2 11 132 0.86 [ 0.76, 0.93 ] 0.99 [ 0.95, 1.00 ]
Yarandi 2008 22 3 2 79 0.92 [ 0.73, 0.99 ] 0.96 [ 0.90, 0.99 ]
Yeo 1998 40 0 6 270 0.87 [ 0.74, 0.95 ] 1.00 [ 0.99, 1.00 ]
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Test 2. Frozen section: Threshold Malignancy or Borderline vs Benign.
Review: Intraoperative frozen section analysis for the diagnosis of early stage ovarian cancer in suspicious pelvic masses
Test: 2 Frozen section: Threshold Malignancy or Borderline vs Benign
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
A ikalin 2014 135 26 3 118 0.98 [ 0.94, 1.00 ] 0.82 [ 0.75, 0.88 ]
Bazot 2006 34 15 2 100 0.94 [ 0.81, 0.99 ] 0.87 [ 0.79, 0.93 ]
Bige 2011 120 27 1 371 0.99 [ 0.95, 1.00 ] 0.93 [ 0.90, 0.95 ]
Boriboonhirunsarn 2004 49 8 3 87 0.94 [ 0.84, 0.99 ] 0.92 [ 0.84, 0.96 ]
Canis 2004 21 25 1 89 0.95 [ 0.77, 1.00 ] 0.78 [ 0.69, 0.85 ]
Cross 2012 497 115 19 808 0.96 [ 0.94, 0.98 ] 0.88 [ 0.85, 0.90 ]
Cuello 1999 70 20 1 398 0.99 [ 0.92, 1.00 ] 0.95 [ 0.93, 0.97 ]
Fanfani 2007 114 29 13 155 0.90 [ 0.83, 0.94 ] 0.84 [ 0.78, 0.89 ]
Garc a 1997 0 10 4 16 0.0 [ 0.0, 0.60 ] 0.62 [ 0.41, 0.80 ]
Gorisek 2009 81 35 1 14 0.99 [ 0.93, 1.00 ] 0.29 [ 0.17, 0.43 ]
Hamed 1993 55 9 0 260 1.00 [ 0.94, 1.00 ] 0.97 [ 0.94, 0.98 ]
Ilker 2011 24 7 4 231 0.86 [ 0.67, 0.96 ] 0.97 [ 0.94, 0.99 ]
Ilvan 2005 117 33 3 351 0.98 [ 0.93, 0.99 ] 0.91 [ 0.88, 0.94 ]
Kokka 2009 19 11 1 19 0.95 [ 0.75, 1.00 ] 0.63 [ 0.44, 0.80 ]
Lim 1997 34 8 1 128 0.97 [ 0.85, 1.00 ] 0.94 [ 0.89, 0.97 ]
Maheshwari 2006 89 7 3 111 0.97 [ 0.91, 0.99 ] 0.94 [ 0.88, 0.98 ]
Malipatil 2013 50 14 3 151 0.94 [ 0.84, 0.99 ] 0.92 [ 0.86, 0.95 ]
Naik 2006 43 12 2 72 0.96 [ 0.85, 0.99 ] 0.86 [ 0.76, 0.92 ]
Pavlakis 2009 246 7 5 587 0.98 [ 0.95, 0.99 ] 0.99 [ 0.98, 1.00 ]
Pinto 2001 67 12 2 162 0.97 [ 0.90, 1.00 ] 0.93 [ 0.88, 0.96 ]
Puls 1997 37 35 1 221 0.97 [ 0.86, 1.00 ] 0.86 [ 0.82, 0.90 ]
Rakhshan 2009 63 11 2 206 0.97 [ 0.89, 1.00 ] 0.95 [ 0.91, 0.97 ]
Rose 1994 115 17 5 246 0.96 [ 0.91, 0.99 ] 0.94 [ 0.90, 0.96 ]
Stewart 2006 259 87 7 561 0.97 [ 0.95, 0.99 ] 0.87 [ 0.84, 0.89 ]
Subbian 2013 58 9 2 48 0.97 [ 0.88, 1.00 ] 0.84 [ 0.72, 0.93 ]
Sukumaran 2014 87 24 1 121 0.99 [ 0.94, 1.00 ] 0.83 [ 0.76, 0.89 ]
Suprasert 2008 48 16 2 46 0.96 [ 0.86, 1.00 ] 0.74 [ 0.62, 0.84 ]
Tangjitgamol 2004 71 8 1 119 0.99 [ 0.93, 1.00 ] 0.94 [ 0.88, 0.97 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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(. . . Continued)
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Taskiran 2008 90 12 2 100 0.98 [ 0.92, 1.00 ] 0.89 [ 0.82, 0.94 ]
Toneva 2012 26 16 2 22 0.93 [ 0.76, 0.99 ] 0.58 [ 0.41, 0.74 ]
Torres 1998 29 2 6 86 0.83 [ 0.66, 0.93 ] 0.98 [ 0.92, 1.00 ]
Twaalfhoven 1991 58 9 2 96 0.97 [ 0.88, 1.00 ] 0.91 [ 0.84, 0.96 ]
Wakahara 2001 54 11 0 122 1.00 [ 0.93, 1.00 ] 0.92 [ 0.86, 0.96 ]
Wang 1998 72 18 1 205 0.99 [ 0.93, 1.00 ] 0.92 [ 0.88, 0.95 ]
Wasinghon 2008 100 44 3 229 0.97 [ 0.92, 0.99 ] 0.84 [ 0.79, 0.88 ]
Wootipoom 2006 74 15 5 119 0.94 [ 0.86, 0.98 ] 0.89 [ 0.82, 0.94 ]
Yarandi 2008 22 5 2 77 0.92 [ 0.73, 0.99 ] 0.94 [ 0.86, 0.98 ]
Yeo 1998 43 13 3 257 0.93 [ 0.82, 0.99 ] 0.95 [ 0.92, 0.97 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 3. Frozen section: Threshold Malignancy vs Borderline or Benign when FS indicated Mal or BOT.
Review: Intraoperative frozen section analysis for the diagnosis of early stage ovarian cancer in suspicious pelvic masses
Test: 3 Frozen section: Threshold Malignancy vs Borderline or Benign when FS indicated Mal or BOT
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
A ikalin 2014 132 0 3 26 0.98 [ 0.94, 1.00 ] 1.00 [ 0.87, 1.00 ]
Bazot 2006 29 1 5 14 0.85 [ 0.69, 0.95 ] 0.93 [ 0.68, 1.00 ]
Bige 2011 115 5 5 22 0.96 [ 0.91, 0.99 ] 0.81 [ 0.62, 0.94 ]
Boriboonhirunsarn 2004 47 0 2 8 0.96 [ 0.86, 1.00 ] 1.00 [ 0.63, 1.00 ]
Canis 2004 18 3 3 22 0.86 [ 0.64, 0.97 ] 0.88 [ 0.69, 0.97 ]
Cross 2012 415 5 82 110 0.84 [ 0.80, 0.87 ] 0.96 [ 0.90, 0.99 ]
Cuello 1999 67 3 3 17 0.96 [ 0.88, 0.99 ] 0.85 [ 0.62, 0.97 ]
Fanfani 2007 106 2 8 27 0.93 [ 0.87, 0.97 ] 0.93 [ 0.77, 0.99 ]
Garc a 1997 7 0 2 1 0.78 [ 0.40, 0.97 ] 1.00 [ 0.03, 1.00 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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(. . . Continued)
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Gorisek 2009 73 0 8 35 0.90 [ 0.81, 0.96 ] 1.00 [ 0.90, 1.00 ]
Hamed 1993 55 1 0 8 1.00 [ 0.94, 1.00 ] 0.89 [ 0.52, 1.00 ]
Ilker 2011 20 0 4 7 0.83 [ 0.63, 0.95 ] 1.00 [ 0.59, 1.00 ]
Ilvan 2005 104 0 13 33 0.89 [ 0.82, 0.94 ] 1.00 [ 0.89, 1.00 ]
Kokka 2009 19 0 0 11 1.00 [ 0.82, 1.00 ] 1.00 [ 0.72, 1.00 ]
Lim 1997 34 0 0 8 1.00 [ 0.90, 1.00 ] 1.00 [ 0.63, 1.00 ]
Maheshwari 2006 86 2 3 5 0.97 [ 0.90, 0.99 ] 0.71 [ 0.29, 0.96 ]
Malipatil 2013 45 0 5 14 0.90 [ 0.78, 0.97 ] 1.00 [ 0.77, 1.00 ]
Naik 2006 40 1 3 11 0.93 [ 0.81, 0.99 ] 0.92 [ 0.62, 1.00 ]
Pavlakis 2009 135 0 15 103 0.90 [ 0.84, 0.94 ] 1.00 [ 0.96, 1.00 ]
Pinto 2001 64 1 3 11 0.96 [ 0.87, 0.99 ] 0.92 [ 0.62, 1.00 ]
Puls 1997 27 1 10 34 0.73 [ 0.56, 0.86 ] 0.97 [ 0.85, 1.00 ]
Rakhshan 2009 60 1 3 10 0.95 [ 0.87, 0.99 ] 0.91 [ 0.59, 1.00 ]
Rose 1994 111 1 4 16 0.97 [ 0.91, 0.99 ] 0.94 [ 0.71, 1.00 ]
Stewart 2006 251 4 8 83 0.97 [ 0.94, 0.99 ] 0.95 [ 0.89, 0.99 ]
Subbian 2013 55 1 3 8 0.95 [ 0.86, 0.99 ] 0.89 [ 0.52, 1.00 ]
Sukumaran 2014 73 1 14 23 0.84 [ 0.74, 0.91 ] 0.96 [ 0.79, 1.00 ]
Suprasert 2008 46 0 2 16 0.96 [ 0.86, 0.99 ] 1.00 [ 0.79, 1.00 ]
Tangjitgamol 2004 62 0 9 8 0.87 [ 0.77, 0.94 ] 1.00 [ 0.63, 1.00 ]
Taskiran 2008 90 0 0 12 1.00 [ 0.96, 1.00 ] 1.00 [ 0.74, 1.00 ]
Toneva 2012 25 0 1 16 0.96 [ 0.80, 1.00 ] 1.00 [ 0.79, 1.00 ]
Torres 1998 28 2 1 0 0.97 [ 0.82, 1.00 ] 0.0 [ 0.0, 0.84 ]
Twaalfhoven 1991 54 0 4 9 0.93 [ 0.83, 0.98 ] 1.00 [ 0.66, 1.00 ]
Wakahara 2001 54 0 0 11 1.00 [ 0.93, 1.00 ] 1.00 [ 0.72, 1.00 ]
Wang 1998 69 0 3 18 0.96 [ 0.88, 0.99 ] 1.00 [ 0.81, 1.00 ]
Wasinghon 2008 82 8 18 36 0.82 [ 0.73, 0.89 ] 0.82 [ 0.67, 0.92 ]
Wootipoom 2006 68 2 6 13 0.92 [ 0.83, 0.97 ] 0.87 [ 0.60, 0.98 ]
Yarandi 2008 22 3 0 2 1.00 [ 0.85, 1.00 ] 0.40 [ 0.05, 0.85 ]
Yeo 1998 40 0 3 13 0.93 [ 0.81, 0.99 ] 1.00 [ 0.75, 1.00 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
121Intraoperative frozen section analysis for the diagnosis of early stage ovarian cancer in suspicious pelvic masses (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
A D D I T I O N A L T A B L E S
Table 1. Accuracy of frozen section malignant results to identify women with malignancy
Frozen section Paraffin section
positive test
Paraffin section
negative test
Malignant Borderline Benign
Malignant True positive False positive False positive
Borderline False negative True negative True negative
Benign False negative True negative True negative
Table 2. Accuracy of frozen section malignant or borderline results to identify women with malignancy
Frozen section Paraffin section
positive test
Paraffin section
negative test
Malignant Borderline Benign
Malignant True positive False positive FPFalse positive
Borderline True positive False positive False positive
Benign False negative True negative True negative
A P P E N D I C E S
Appendix 1. International Federation of Gynecology and Obstetrics (FIGO) staging of ovarian
cancer
Stage I . Stage I consists of tumour limited to the ovaries or fallopian tubes.
• Stage IA includes the following: tumour limited to one ovary (capsule intact) or fallopian tube. No tumour on the external
surface of the ovary or fallopian tube. No malignant cells in ascites or peritoneal washings
• Stage IB includes the following: tumour limited to both ovaries (capsules intact) or fallopian tubes. No tumour on the external
surface of the ovaries or fallopian tubes. No malignant cells in ascites or peritoneal washings
• Stage IC includes tumour limited to one or both ovaries or fallopian tubes, with any of the following: Stage IC1: Surgical spill.
Stage IC2: Capsule ruptured before surgery, or tumour on ovarian or fallopian tube surface. Stage IC3: Malignant cells in the ascites
or peritoneal washings
Stage II . In stage II tumour involves one or both ovaries or fallopian tubes, with pelvic extension (below pelvic brim) or primary
peritoneal cancer.
• Stage IIA: Extension, implants or both on at least one of the following: uterus, ovaries and fallopian tubes.
• Stage IIB: Extension to other pelvic intraperitoneal tissues
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Stage III . In stage III, tumour involves one or both ovaries or fallopian tubes, or primary peritoneal cancer, with cytologically or
histologically confirmed spread to the peritoneum outside the pelvis and/or metastasis to the retroperitoneal lymph nodes.
• Stage IIIA includes the following: Stage IIIA1: Positive (cytologically or histologically proven) retroperitoneal lymph nodes only.
Stage IIIA1(i) Metastasis up to 10 mm in greatest dimension. Stage IIIA1(ii) Metastasis more than 10 mm in greatest dimension. Stage
IIIA2: Microscopic extrapelvic (above the pelvic brim) peritoneal involvement with or without positive retroperitoneal lymph nodes
• Stage IIIB involves macroscopic peritoneal metastasis beyond the pelvis up to 2 cm in greatest dimension, with or without
metastasis to the retroperitoneal lymph nodes.
• Stage IIIC involves macroscopic peritoneal metastasis beyond the pelvis more than 2 cm in greatest dimension, with or without
metastasis to the retroperitoneal lymph nodes. Stage IIIC includes extension of tumour to the capsule of liver and spleen without
parenchymal involvement of either organ.
Stage IV . Stage IV consists of distant metastasis, excluding peritoneal metastases, and includes the following:
• Stage IVA: pleural effusion with positive cytology.
• Stage IVB: parenchymal metastases and metastases to extra-abdominal organs (including inguinal lymph nodes and lymph
nodes outside of the abdominal cavity)
Appendix 2. MEDLINE (Ovid) search strategy
1. exp Ovarian Neoplasms/
2. (ovar* adj5 (cancer* or tumor* or tumour* or adenocarcinoma* or carcinosarcoma*or cystadenocarcinoma* or carcinoma* or
malignan* or neoplas* or carcinogen* or teratoma* or metasta* or mass or masses)).tw,ot.
3. (thecoma* or luteoma*).tw,ot.
4. 1 or 2 or 3
5. Frozen Sections/
6. (FS or FSA or IFS or IFSA).tw,ot.
7. (frozen or quick) adj5 section*.tw,ot.
8. ((intraoperative or intra-operative) adj5 (consultation* or histolog* or diagnos* or patholog*)).tw,ot.
9. (cryosection* or cryogenic*).tw,ot.
10. (fresh or frozen) adj5 tissue*).tw,ot.
11. 5 or 6 or 7 or 8 or 9 or 10
12. 4 and 11
13. exp animals/ not humans.sh.
14. 12 not 13
key: tw=textword, ot=original title
C O N T R I B U T I O N S O F A U T H O R S
• Guarantor of the review: RN
• Conceiving the idea: RN, AP, PC
• Designing and coordinating the review: NR, RN
• Data collection for the review; designing search strategies; undertaking searches; screening search results: TL, NR, JH
• Organising retrieval of papers: NR, AB
• Screening retrieved papers against inclusion criteria: NR, AP
• Appraising quality of papers: NR, AB, RS
• Extracting data from papers: NR, AB, CF, RS, SM
• Providing additional data about papers: NR
• Obtaining and screening data on unpublished studies: NR, AP
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• Data management of the review: NR
• Entering data into RevMan: NR, SM, RS
• Analysis and interpretation of data: SM, NR, RS
• Providing a methodological perspective; providing a clinical perspective; providing a policy perspective; providing a consumer
perspective: RN, NR, AP, PC
• Writing the review: NR, SM
• Providing general advice on the review: RN, NR, AP, PC, KG
• Securing funding for the review: NR, RN
D E C L A R A T I O N S O F I N T E R E S T
PC, AP and RN were authors in a study that met the inclusion criteria in the review.
NR: none known.
AB: none known.
SM: Received payment for methodology work on review.
RS: none known.
CF: none known.
KG: none known.
S O U R C E S O F S U P P O R T
Internal sources
• No sources of support supplied
External sources
• Department of Health, UK.
NHS Cochrane Collaboration programme Grant Scheme CPG-10/4001/12
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
We clarified that we used sensitivity and specificity in our primary analysis to assess accuracy.
We clarified that our objectives included assessment for the following two thresholds for frozen section.
1. Test positive is cancer.
2. Test positive is cancer and borderline.
The reference standard test threshold for all analyses is test positive cancer and test negative borderline or benign.
The secondary objective of the protocol (renamed secondary objective #1 in the review) could not be addressed due to lack of data in
included studies. We included an additional analysis, Secondary objective #2, which was the closest substitute to secondary objective
#1, which could be addressed.
There was insufficient data to examine heterogeneity except for pathologist reader experience. We did not assess reporting bias, based
on recommendations in the Cochrane Handbook for Diagnostic Test Accuracy Reviews.
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